Chemotherapeutic Studies on Experimental T. congolense Infections by Calver, Kathleen Mildred
CHEMOTHERAPHJTIC STUDIES ON EXPERIMENTAL T. CONGOLESE INFECTIONS.
THESIS 
f o r  The Degree o f  
D octo r o f  P h ilosophy
i
subm itted  by
KATHLEEN MILDRED CALVER, B. Sc. 
The U n iv e rs ity  o f  Glasgow*
1945.
ProQuest Number: 13850438
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13850438
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
The woric described  in  t h is  th e s is  was c a rr ie d  o u t in  the  
B a c te r io lo g y  Department o f  th e  U n iv e rs ity  o f  GLasgow under the  
guidance o f  P ro fe sso r C,H. Browning,
I  have to  thank the  M edica l Research C ouncil f o r  t h e i r  
support.
f
.CONTENTS
' r -
Page
In t r o d u c t io n 1
Section  I *  Experim enta l s t ra in s  o f  T. congolense. 4
S tra in  I  4
Course o f  the  in fe c t io n  5
Mean ten  an ce o f  s t ra in  o
S tra in  I I  6
Treatment and methods o f  e s tim a tin g  i t s  e f fe c ts  8
S ection  I I ,  Treatment o f  experim enta l T. congole n se  in fe c t io n s  
in  m ice w ith  7 amino 9(p-am inophenyl) 10 m ethyl 
phenan th rid in ium  c h lo r id e  — No. 897 1°
T o x ic ity  10
Acute in fe c t io n s  — S tra in s  I  and I I  11
E f fe c t  o f  s ize  o f  dose 11
E f fe c t  o f  stage o f  in fe c t io n  a t the  tim e 
o f  trea tm en t 11
Relapses — t im e - in te rv a l a f te r  trea tm en t 12
S tra in  I  1.2
S tra in  I I  14
Treatment o f  ch ron ic  in fe c t io n s  — S tra in s  I  and IT. IS  
In fe c t io n s  w ith  a ch ron ic  s t ra in — S tra in s  I  and IT . 16 
Summary 16
P ro p h y la c tic  a c tio n  17
O ra l a d m in is tra tio n  o f  No, 897 17
S ection  I I I .  Treatment w ith  o th e r  drugs 19
P henanthrid in ium  s e r ie s  19
Di ami d ine  s e r ie s  23
Q iin d o lin e  metho c h lo r id e  24
Secti on IV  /
Page
S ection  IV , Treatment o f  re lapses
i
S tra in  I I  re lapses
Treatment o f  re lapses w ith  doses o th e r than
1/L5,000 g . ?8
S tra in  I  re lapses  29
D iscussion  31-
S ection  Attem pts to  develop s t ra in s  o f  T. congolense re  s i s ta n t
to  drug No, 897 33
S tra in  I  34
S tra in  I I  3?
Summary 39
S ection  V I. Immunity responses a f te r  cure 40
Methods o f  dem onstra ting im m unity 41
Treatm ent a f te r  r e in fe c t io n :  O ther te s ts
c o n firm in g  th a t  s t e r i l i s a t io n  had been
e ffe c te d : A p p lic a t io n  o f  the  R ieckenberg
adhesion phenomenon 41
S tra in  I  44
Cured acme in fe c t io n s  re in o c u la te d  w ith  acme 
p a ra s ite s  44
do. ch ro n ic  p a ra s ite s  45
Cured ch ron ic  in fe c t io n s  re in o c u la te d  w ith
acme p a ra s ite s  45
do. ch ro n ic  p a ra s ite s  46
Is o la te d  ins tan ces  o f  im m unity to  re in o c u la t io n
w ith  chronic trypanosomes 47
Increased s u s c e p t ib i l i t y  to  re in o c u la t io n  w ith  
ch ron ic  trypanosomes shown by cured m ice 47
R esu lts  o f  re in o c u la tio n  a f te r  cure o f  re lapses 48
Anomalous responses to  re in o c u la tio n  49
Resistance to an inoculum  o f  ch ro n ic  trypanosomes 50 
P rogress ive  /
Pa ye
P rog ress ive  a l te r a t io n  in  the  an tigens
o f  the  trypanosomes o f  a ch ron ic  in fe c t io n  SI
f ix a t io n  o f  the  im m unologica l cha rac te rs  o f  a 
chrom e in fe c t io n  by passage S2
The im m unological cha rac te rs  o f  ch ron ic
trypanosomes as a ffec ted  by continued passage ^3
Summary and conc lus ions in  the  l i g h t  o f
E h r lic h Ts receptor theo iy  g4
S tra in  I I  53
Cured acme in fe c tio n s  re inocu la ted  w ith  acme 
p a ras ite s  58
R esu lts  o f  repeated re in o c u la tio n s  and re trea tm en ts  59
Incubation  pe riod  o f  re in fe c te d  mice 60
Cured acme in fe c tio n s  re inocu la ted  w ith  chronic 
trypanosomes 6l
Cured chronic in fe c t io n s  rei.noculated w ith  acme 
tiypano soraes 6l
Summary and d iscuss ion  6l
Cross Im m unity responses 63
Section V I I» F ie ld  t r i a ls  o f  No, 897 and No, 1553 on T, congolense
in fe c t io n s  65
Compound No* 897 65
Compound No* 1553 $3
Discussion o f  the re s u lts  o f  f ie ld  t r i a ls  in
the l ig h t  o f  experimental work 69
References. -ji
Tables, Appendix.
INTEDDOCTION
/
-  1 -
In t ro d u c t io n
The name nagana i s  a p p lie d  to  a se rio u s  disease o f  c a t t le  and 
o th e r  dom estic anim als in  A f r ic a  — ts e ts e - f ly  d isease — which i s  
ch a ra c te ris e d  e s p e c ia lly  by w asting  and anaemia and i s  now known to  be 
due to  in fe c t io n  w ith  trypanosomes. The p io n e e r work o f  Bruce and h is  
assoc ia tes  p o in te d  to  the  causal agent be ing the  tiypanosome known as 
T. b ru c e i; b u t la t e r  in v e s t ig a t io n s  have shown th a t  so f a r  as c a t t le  
a re  concerned T. congolense i s  p roba b ly  the  most im p o rta n t o f  the  
p a ra s ite s  re sp o n s ib le  f o r  nagana. I t  resembles T. b ruce i and i t s  
a l l i e s ,  T. rhodesiense and T. gambiense, and a lso the  T. e van s i  group 
in  th a t  m ice and c e r ta in  o th e r  la b o ra to ry  animals are s u s c e p tib le  to 
experim enta l in fe c t io n ;  thus i t  le nds  i t s e l f  f a i r l y  r e a d i ly  to  exact 
s tudy. On the  o th e r  hand, T. congolense d i f f e r s  from a l l  the  above- 
named trypanosomes m o rp h o lo g ic a lly , s ince  i t  has very l i t t l e  in  the  
n a tu re  o f  a fre e  flageH um ; and a lso , in fe c t io n s  due to  i t  are p o o r ly  
in flu e n c e d  by the  chem otherapeutic agents which a c t v ig o ro u s ly  on the  
o th e r  trypanosomes mentioned above, e .g . trypa nb lue , t r y p a f la v in ,  
a rs e n ic a ls , suramin (Bayer 205, o r  germ anin), s ty ry l~ 3 L 4 , e tc . The 
ch lo rin a te d * pa ra fuchs in  dye, trypa rosan , and bismuth s a lts  have some 
th e ra p e u tic  a c tio n ,w h ich , however, does n o t seem to  be capable o f  
p r a c t ic a l a p p lic a tio n .
The problem o f  the  cure o f  c a t t le  in fe c te d  w ith  T. congolense i s  
exceed ing ly  im p o rta n t econom ica lly  and many attem pts have been made 
to  d isco ve r e f f ic ie n t  drugs. In  the  f i e l d  the  f i r s t  compound w ith  
cons ide rab le  e f fe c t  ?/as found to  be t a r t a r  em etic; Hornby (1919) 
re p o rte d  favo u ra b ly  on i t s  use and Richardson (1928) by means o f  t h is  
drug c o n tro lle d  severa l n a tu ra l ou tbreaks, a f fe c t in g  la rg e  numbers o f
/
o f animals. However, owing to the extremely i r r i t a n t  nature o f the 
solution ta r ta r  emetic must be in jected  intravenously, which presents 
considerable d if f ic u lt ie s  under f ie ld  conditions, also the therapeutic 
dose approximates to the toxic l im it .  A more easily  administered and 
better to lerated compound, antimosan, a complex o f antimony and 
pjrrocatechin, was next extensively tested; success with repeated 
dosage was reported by Parkin (193^)> who observed no objectionable 
sequelae, by Evans (193^) ^  To it (193^*
An organic compound, Surfen C, l ik e  antimosan o f German o rig in , 
stated to be an amino-quinoline derivative, was claimed to be curative  
in  a singLe intramuscular dose (lensch 1937)* Van Rensburg (1938) from 
h is  survey o f the published work on treatment vdth th is  drug, concluded 
that results, in  respect both o f effic iency and lo ca l reaction, were 
conflic ting . He obtained unsatisfactory results in  c a ttle , using several 
samples o f the drug, since i t  had been claimed that the e ffic iency o f 
d iffe re n t batches varied. Evans (193^) on ^he other hand, considered 
that a single dose was superior to a course of antimosan. I t  appears, 
however, that none of the above drugs is  highly e ffective  in  c a ttle .
Browning, Morgan, Robb and Walls (193^) in  the course o f  
investigations on compounds o f the phenanthridinium series synthesised 
by Morgan and Walls, showed that 7 amino-9 (j^-aminophenyl) -10-m ethyl- 
phenanthridinium chloride (No. 897) — 23 o f Morgan and Walls, 1938 — 
exerted a d e fin ite  therapeutic e ffec t on T. congolense in  mice; but in  
th e ir  o rig in a l experiments the curative dose approximated to the maximum 
to lerated. Further investigations showed, however, that much more
favourable results might be obtained (Browning, Browning and Robb, 1940); 
and an in ve s tig a tio n  o f the reason fo r the discrepancy between the /
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th e  e a r l ie r  and the  la t e r  re s u lts ,  in  which the  p resen t au tho r took p a r t ,  
has y ie ld e d  a s a t is fa c to ry  exp lana tion  f o r  the  d if fe re n c e ; and the  
c o n d it io n s  have been d e fin e d  under which experim enta l in fe c t io n s  w ith  
T. congolense in  m ice may be cured w ith  a sm all f r a c t io n  o f  the  
to le ra te d  dose o f  the  drug, see se c tio n  I I  — f o r  re fe re n ce  to  f i e l d  
t r i a l s  see sec tion  VTI. T h is  opened th e  way f o r  an in v e s t ig a t io n  o f  
the  im m unologica l p ro p e r t ie s  o f  T. congolense. which have tu rned  o u t to  
d i f f e r  m arkedly from those o f  the  T. b ru ce i group which had h ith e r to  
been examined from th is  p o in t  o f  v iew  by va rio u s  in v e s t ig a to rs  (see 
s e c tio n  V I ) .  A s e r ie s  o f  substances re la te d  chem ica lly  to  No. 897 
has also been s tud ied  (s e c tio n  I I I ) .  A p a r t  o f  the  r e s u lts  has been 
p u b lish e d  in  summary form  (Browning and C a lver, 1943) > b u t th e  fo llo w in g  
account embodies th e  experim enta l work a c tu a lly  c a r r ie d  o u t by the  
a u th o r. Subsequently c e r ta in  am idine compounds have been found a c t iv e  
a g a in s t T. congolense (s e c tio n  I I I ) .
*
SECTION I
EXPERIMENTAL STRAINS OF T. CONGOLENSE.
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Experim enta l S tra in s  o f  T. Congolense.
Two la b o ra to ry  s tra in s  o f  T. congolense have been used th roughou t 
th e  experim ents; the  o r ig in ,  cha rac te rs  o f  the  in fe c t io n  and methods 
o f  m a in ta in in g  one s t ra in  (S tra in  I ) ,  have been f u l l y  described  (Browning, 
C appell and Gulbransen 1934)> they  are  now summarised.
S tra in  I
A r a t  in fe c te d  w ith  t h is  s t ra in  was rece ive d  th rough Dr. C.M. Wenyon, 
Wellcome Bureau o f  S c ie n t i f ic  Research, London, from Mr. H.E. Hornby, 
D ire c to r  o f  V e te r in a ry  S e rv ices , Tanganyika T e r r i to r y .  P r io r  to  passage 
th rough  ra ts  the  s t ra in  had been passed through a ra b b it .  Continuous 
passage th rough  m ice has been m a in ta ined  s ince  December I 929. In  o rd e r 
to  tra n s m it the  s t ra in ,  fre s h  m ice are in o c u la te d  subcutaneously w ith  
a suspension in  s a lin e  o f  in fe c te d  b lood; the  inoculum  fo r  each mouse 
c o n s is t in g  o f  6 to  8 drops o f  b lood  taken from the  t ip  o f  the  t a i l  o f  
an in fe c te d  mouse in  which the  p a ra s ite s  are abundant, in  0 .5  c. c. normal 
s a lin e . Scanty trypanosomes can u s u a lly  f i r s t  be demonstrated in  a 
f re s h  f i lm  o f  th e  b lood w ith  the  1 /6 "  o b je c t iv e  on the  4 th  o r  5th  day 
a f te r  in o c u la t io n ;  the  fo llo w in g  day the  numbers have in c rea sed  to  
3 to  12 p e r f i e l d  and by the  3r(* hay they are abundant, i . e .  a t  the  
”  f a s t i  glum” . The ta b le  below g ives  symbols used to  in d ic a te  th e  
progress o f  th e  in fe c t io n .
-  = no p a ra s ite s
+ v l = ve ry  scanty p a ra s ite s
+ 1 = 1  p a ra s ite  in  every 2nd o r  3**^ f i e l d  
+ = 1 to  3  p a ra s ite s  p e r f i e l d
++ = 4 to  12 p a ra s ite s  p e r f i e l d
+++ = an uncountable number o f  p a ra s ite s  p e r f ie l d  ( fa s t ig iu m ) .
The /
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The stage o f  fa s tig iu m  may be sa id  to  have been reached on the  f i r s t  
occasion on which an uncountab le  number o f  trypanosomes are  observed 
fo llo w in g  a p ro g re ss ive  in c re a se  in  t h e i r  numbers, e .g . in  mouse 1784H 
th e  in fe c t io n  had reached th e  fa s tig iu m  on th e  8 th  o f  March (see 
appended ta b le )  •
Table - Mouse No. 1784H.
1 .3 .4 4 . in o c u la te d
6 .3 + v l
7 .3 +
3 .3 +++ ( fa s t ig iu m )
9 .3 +++
10 .3 1 1 1 TTT
1 3 .3 -
1 5 .3 ++
1 7 .3 +-H-
20.3 +++
22.3 +++
Course o f  the  in fe c t io n *  Three courses o f  in fe c t io n  subsequent to  
the  fa s tig iu m  were o r ig in a l ly  described , v iz .  acute ( in  which death occurs
in  a few days w ith  the  tiypanosomes p e rs is t in g  in  la rg e  numbers), re la p s in g  
i
and ch ro n ic . The re la p  s in g -c h ro n ic  course i s  s t i l l  th e  most common, w ith  
the  f i r s t  n eg a tive  p e r io d  o c c u rr in g  from 2 to  5 days a f te r  the  fa s tig iu m . 
The trypanosomes may never d isappear com ple te ly  from th e  b lood ; o r  aga in , 
they  may p e rs is t  in  cons ide rab le  numbers, a lthough f lu c tu a t in g  f o r  days 
o r  weeks. During the  f i r s t  50 passages o f  the  s t ra in ,  be fo re  i t  became 
accommodated, about 1 mouse in  7 f a i le d  to  become in fe c te d  w ith  the
usua l inoculum ; s ince  then , however, anim als re s is ta n t  to  in fe c t io n  
a lthough  s t i l l  met w ith  o c c a s io n a lly , are very  e x c e p tio n a l. A s l ig h t  
decrease in  the  in c u b a tio n  p e r io d , which i s  described as the  in te r v a l  
i n  days between the  subcutaneous in o c u la t io n  and the  f i r s t  appearance o f  
p a ra s ite s  in  the  H ood , was observed in  the  course o f  e a r ly  passages; the
/
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th e  p e r io d  be ing  5 to  10 days f o r  the  m a jo r i ty  o f  an im als o f  the  f i r s t  
50 passages, 4 to  9 days f o r  the  n e x t 50 and 4 to  8 days f o r  passages 
100 to  I 50. A f te r  continuous transm iss ion  through m ice f o r  ove r 14 
years no fu r th e r  no tew orthy  a lte ra t io n  has taken p la ce  in  the  in c u b a tio n  
p e r io d . T h is  i s  shown in  Table I .
Maintenance o f  the  s t ra in .  The s t ra in  i s  m a in ta ined  by passage to  
a fre s h  animal im m ed ia te ly  the  p a ra s ite s  become abundant; t h is  i s  
designated as a f a s t ig ia l l y  propagated s t r a in .  The stock s t ra in  which has 
been propagated in  t h is  way now fo r  many hundred passages i s  re fe r re d  to  
as the  acme s t ra in  o f  T. congolense I ;  and in  t h is  connection the  
fa s tig iu m  i s  termed the  acme. In  the  l i g h t  o f  the  p resen t work, i t  i s  
considered h ig h ly  im p o rta n t to  t ra n s fe r  the  trypanosomes to  a fre s h  hos t 
im m ed ia te ly  the  fa s tig iu m  (acme) i s  reached in  o rd e r th a t  t h e i r  
im m unologica l cha rac te rs  may remain unchanged. When th e  in fe c t io n  becomes 
re la p  s in g - ch ron ic  and the  p a ra s ite s  a f te r  d im in is h in g  in  th e  b lood o r  
d isappearing , again become numerous, the  event i s  spoken o f  as a re lap se  
fa s tig iu m .
S tra in  I I .
Strain I I  mentioned by P. Browning (19Z$) was received in  a guinea- 
p ig  from Mr. H.E. Hornby; the previous history o f th is  stra in  is  unknown. 
Immediately on a rriva l a t th is  laboratory on December 9th , 1933, blood
from the  in fe c te d  p ig  was passed to  mice and s ince  then the  s t ra in  has 
been co n tin uous ly  propagated through m ice in  the  form o f  an acme s t ra in  
by the  methods described . Table I I  shows the  percentages o f  m ice w ith  
th e  same in cu b a tio n  p e r io d s  and t o ta l  numbers o f  mice in  groups a t  f i r s t  
o f  10 o r  20 passages and la t e r  o f  100. Only a s l ig h t  sho rten ing  o f  the  
in c u b a tio n  p e rio d  was observed as the s t ra in  became accommodated to  /
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to mice; th is  corresponds with observations vdth Strain I .  By the 
80th  to 100th passages the incubation period was 3 day s for over 50 per 
cent, o f the animals and 4 days fo r most o f the rest; a fte r  passage 
fo r 11 years the incubation period is  now s lig h tly  longer, being 4 or 5 
days fo r about 70 Per cent. (Table I I ) .
U n lik e  th e  e a r ly  passages o f  S tra in  I ,  in  the  f i r s t  50 passages o f  
S tra in  I I  o n ly  1 mouse f a i le d  to  become in fe c te d  w ith  the  o rd in a ry  
inoculum ; a re in o c u la t io n  was success fu l, th e re  being no d if fe re n c e  in  
in c u b a tio n  p e r io d  from th a t  o f  a fre s h  mouse s im i la r ly  in o c u la te d .
Thus app re c ia b le  n a tu ra l re s is ta n c e  to  t h is  s t ra in  was n o t  e v iden t 
even In  e a r ly  passages.
The p a ra s ite s , as w ith  S tra in  I ,  a f te r  appearing in  the  b lood, 
in c re a se  ra p id ly  in  numbers, becoming abundant 1 o r  2 days la t e r ,  i . e .  
the  acme stage i s  commonly reached on the  5 th  o r  6 th  day. In  the  e a r ly  
passages, however, th e  s t ra in  took seve ra l days lo n g e r than a t p resen t 
to  reach th e  acme stage. The course o f  the  in fe c t io n  in  12 anim als o f  
the  f i r s t  100 passages was e xce p tio n a l, in  th a t  the  p a ra s ite s  a f te r  
appearing in  the  hLood in  scanty numbers, increased  to  + o r  ++ b u t 
d im in ished  again be fo re  f i n a l l y  reach ing  the  +++ stage, w hich was n o t
a tta in e d  u n t i l  from 9 to  20 days a f te r  in o c u la t io n ;  e .g .
mouse 38A 33* 7*34 in o c u la te d
3. 8 . 4 v l
4. 8 . +1
5.8 . ++
6.8. +1
7*8. +1
8.8. +
9*8. +
10.8. +
11.8. +
12.8. ++
13.8  • +++
14.8* +++
15. 8 . +++
No /
No abnormalities o f th is  nature have been noted in  la te r  passages up to 
date — to almost the T^Oth.
The numbers o f  trypanosomes in  the  b lood in  S tra in  I I  in fe c t io n s  
may f lu c tu a te  subsequent to  the  acme stage, b u t o n ly  in  vei*y e xce p tio n a l 
cases do they d isappear com ple te ly  — tw ice  in  many hundreds — o r  even 
f a l l  to  sm all numbers. Death o f  the  h os t may occur from 2 days to  
seve ra l weeks a f te r  the  acme stage. Thus, in  m ice, S tra in  I I  i s  more 
v i r u le n t  than S tra in  I ;  b u t n e ith e r  a t ta in s  the  v iru le n c e  o f  T. b ru ce i 
f o r  those anim als. Considerab le  en la rgeaent o f  the  spleen i s  a fe a tu re  
o f  ch ron ic  in fe c t io n s  w ith  both  s tra in s .
Treatment and Methods o f  E s tim a tin g  i t s  E ffe c ts .
In  the  trea tm en t o f  in fe c te d  mice the  drug i s  g iven subcutaneously 
in  a s in g le  dose in  the  p ro p o rt io n  o f  1 c. c. o f  aqueous s o lu t io n  c o n ta in in g  
th e  amount o f  drug s ta te d  p e r 20 g. body w e igh t; e .g . a dose o f  1/1,000 g. 
means th a t  a mouse weigh ing 20 g. would re c e iv e  1/1,000 g. d is s o lv e d  in  
1 c. c. o f  w a te r. M ice weigh ing between 13 and 25 g. were u s u a lly  se lec te d  
f o r  th e  te s ts .  A f te r  trea tm en t, a sm all drop o f  b lood from the  t a i l  i s  
examined d a i ly  o r  every 2nd day f o r  a month and fre q u e n t ly ,  a t  le a s t  
weekly, d u rin g  the  n e x t month, then a t m onthly in te r v a ls  f o r  some tim e  —
4 to  6 months — be fo re  cure i s  re p o rte d . Permanent disappearance o f  the  
p a ra s ite s  from the  b lood, and s t e r i l i s a t io n  o f  the  in fe c t io n ,  i . e .  cure, 
re s u lts  from trea tm en t w ith  an e f fe c t iv e  try p a n o c id a l agent. Table I I I  
shows re p re s e n ta tiv e  d e ta i ls  f o r  each s t ra in  o f  the  exam inations o f  a 
cured in fe c t io n ,  a re lapse  and an in fe c t io n  u n in flu e n ce d  by the  drug. The 
tim e  taken f o r  th e  trypanosomes to  d isappear v a r ie s  w ith  the  drug and the  
s t ra in  o f  trypanosome. On the  o th e r hand, i f  the  drug has o n ly  a marked /
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mariced try p a n o c id a l a c tio n  bu t i s  n o t capable o f  e f fe c t in g  cure, o r  
i f  a subcufcative dose o f  an e f fe c t iv e  one i s  adm in is te red , the  
trypanosomes w i l l  d isappear from the  b lood f o r  a tim e , o n ly  to  reappear 
la t e r  and in c rea se  in  numbers, as in  th e  u n tre a te d  an im a l. Th is  
reappearance o f  the  trypanosomes i s  termed a re la p se . The course 
fo llo w e d  by the  in fe c t io n  a f te r  tre a tm e n t w ith  a substance devo id  o f  
t ry p a n o c id a l p ro p e r t ie s  i s  id e n t ic a l  w ith  th a t  in  u n tre a te d  anim als.
\
SECTION I I
TREATMENT OF EXPERIMENTAL T. CONGOLENSE 
INFECTION IN  MICE HTH NO.897.
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Treatm ent o f  Experim enta l T. Congolense In fe c t io n  in  M ice w ith  
7 amino-9  (^-am ino-phenyl) 10-m e th y l-p h e n a n th rid in iu m  c li lo r id e  — No.897.
The drug used th roughou t t h is  in v e s t ig a t io n ,  un less  o the rw ise  
s p e c if ie d , i s  7 amino-9  (£-am ino-phenyl) 10-m e th y l-p h e n a n th iid in iu m  c h lo r id e , 
No. 897 — 23 (Morgan and W alls  — 1938)* prepared a t  the  Chemical Research 
L a b o ra to ry , Teddington, M iddlesex. The drug i s  a dark red  c r y s ta l l in e  
compound which d is s o lv e s  in  ho t w a ter to  g ive  a s ta b le  1 p e r cen t, s o lu t io n  
o f  a d e a r  o range-red  c o lo u r and o f  pH ju s t  above 7*0. The s o lu t io n  may 
be b o ile d . I t s  c o n s t itu t io n  may be represented g ra p h ic a lly  as fo l io w s : -
T o x ic ity .
A dose o f  1 /1 ,000  g. subcutaneously i s  w e ll to le ra te d  bo th  g e n e ra lly  
and lo c a l ly ,  w h ile  1/750 S* k i l l s  a lm ost 3  ^ p e r cent, o f  m ice — u s u a lly  
w ith in  24 hours — and causes h a ir  to  d isappear from areas o f  the  back 
a t  th e  s i t e  o f  the  in je c t io n  in  most o f  the  s u rv iv o rs  and n e c ro s is  o f  the  
subcutaneous t is s u e s  in  some o f  thetf; 1/500 g. k i l l s  about 75 p e r cent, 
a c u te ly  and la rg e r  doses are always f a ta l .  The ta b le  below g ives  d e ta i ls
o f  m ice used in  t o x ic i t y  experim ents.
Dose o f  drug. No. o f  s u rv iv a ls . T o ta l No. tre a te d .
1/ 3D0 g. 0 2
1/400 g. 0 8
1/500 g. 3 12
1/750 g. 33 42
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Acute In fe c t io n s  — S tra in s  I  and I I .
E f fe c t  o f  s iz e  o f  dose. In  the  p re se n t woik, the  s a t is fa c to ry  
re s u lts  o f  Browning, Browning and Robb (1940) have been confirm ed and 
extended and in v e s t ig a t io n s  on the  c u r a b i l i t y  o f  both  s t ra in s  a t  v a r io u s  
stages o f  in fe c t io n  have been c a rr ie d  o u t. Table IV  shows th e  dose o f  
drug, stage o f  in fe c t io n  a t trea tm en t and re s u lts  f o r  bo th  s t ra in s  when 
trea tm en t was given a t  the  e a r ly  (+ v l)  o r  the  acme (+++) stage. I t  i s  
seen th a t  S tra in  I  responds b e t te r  to  trea tm en t than S tra in  I I .  Thus 
o f  41 m ice in fe c te d  w ith  the  form er 25 (a lm ost 61 p e r c e n t.)  were cured 
a t  th e  acme stage by a dose o f  1/ 75*000 to  l/ lO O , 000 g . , w h ile  
1 /10 ,000 g. to  l/L 5 *0 0 0  g. cured 26 o u t o f  62 (a lm ost 42 p e r c e n t.)  
in fe c te d  w ith  the  l a t t e r  a t the  same stage. W ith each s t ra in  doses 
sm a lle r than those m entioned fa i le d  to  e f fe c t  cure.
E f fe c t  o f  stage o f  in fe c t io n  a t the  tim e o f  tre a tm e n t. W ith  both  
s t ra in s  the  stage o f  in fe c t io n  a t the  tim e o f  trea tm en t in flu e n c e s  the  
c u r a b i l i t y  o f  the  d isease, the  drug be ing more e f fe c t iv e  when given a t  
the  acme than a t the  e a r ly  stage when p a ra s ite s  are scanty in  the  b lood. 
Thus w ith  S tra in  I ,  a dose o f  1/75*000 g. o r  l/LD 0 ,000  g . , which cured 
61 p e r coat, a t acme, when given a t th e  e a r ly  stage cured o n ly  2 o u t o f  
32 m ice (6  p e r cent.); and w ith  S tra in  I I  a dose o f  1 /L0 ,000  g. o r  
l / L 5,000 g . , which cured 42 p e r cent, a t  acme, y ie ld e d  o n ly  1 cure o u t o f  
15 a t th e  e a r ly  stage (7  p e r c e n t . ) .  Both these re s u lts  are h ig h ly  
s ig n i f ic a n t  s t a t i s t i c a l l y ^ .  Th is  in d ic a te s  th a t im m unity re a c tio n s  
p ro b a b ly  p la y  a cons iderab le  p a r t  in  h e lp in g  to  e f fe c t  cure. A f te r  y
^  A l l  e s tim a tio n s  o f  s t a t i s t i c a l  s ig n if ic a n c e  are made accord ing  to  a 
m o d if ic a tio n  o f  U s h e r1 s f a c to r ia l  method (Loewenthal and W ilson, 1939}.
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A f te r  a d m in is tra tio n  o f  th e  drug in  a c u ra t iv e  dose, trypanosomes seldom 
d isappear from the  b lood w ith in  24 to  48 hours; as a r u le ,  they p e rs is t  
f o r  2 to  3 days, sometimes in c re a s in g  in  numbers, e s p e c ia lly  when 
tre a tm e n t i s  g iven a t  th e  e a r ly  stage. These fa c ts  a lso support the  
v iew  th a t  the  in te rv e n t io n  o f  a n tib o d ie s  a s s is ts  the  a c tio n  o f  th e  drug.
The obse rva tio n  th a t  more favou rab le  r e s u lts  are ob ta ined  by t re a t in g  
T. congolense in fe c t io n s  in  mice a t the  acme ra th e r  than a t  an e a r l ie r  
stage, i s  nove l and i s  in  c o n tra s t to  the  trea tm en t o f  the  acute type 
o f  in fe c t io n ,  e .g . w ith  T. b ru c e i. W ith the  l a t t e r  species i t  i s  
g e n e ra lly  agreed th a t  as the  in fe c t io n  progresses the more d i f f i c u l t  i t  
becomes to  e f fe c t  cure.
From Table IV  i t  can be seen th a t  th e  a c tio n  o f  the  drug shows 
cons ide rab le  re g u la r ity  in  r e la t io n  to  the  dose. O ccasional fa i lu r e s ,  
however,may r e s u lt  from trea tm en t w ith  an amount o f  the  drug which i s  
w ith in  the  c u ra tiv e  range. Th is  i s  seen in  S tra in  I ,  v.here in  a singLe 
case th e re  was f a i lu r e  w ith  the  r e la t iv e ly  la rg e  dose o f  l / L 5,000 g. g iven 
a t acme, in  s p ite  o f  a lm ost 5^ pe r cent, o f  those tre a te d  a t  the  same 
stage w ith  1/100,000 g. being cured. F a ilu re  in  such cases it, of course, 
most p robab ly  due to  v a r ia t io n  in  the  in d iv id u a l anim al.
Relapses — Time In te r v a l a f te r  Treatm ent.
S tra in  I .  The m a jo r ity  o f  re lapses occur between the 9 th  and 14 th  
days a f te r  n o n -c u ra tiv e  trea tm en t which te m p o ra r ily  c le a rs  the  b lood o f  
p a ra s ite s . A n a lys is  o f  the  re s u lts  recorded in  Table IV  has been c a rr ie d  
o u t in  o rd e r to  determ ine i f  (a) the  dose o f  the  drug o r  (b) the  stage 
o f  th e  in fe c t io n  a t  the  tim e o f  trea tm en t in flu e n c e s  the  le n g th  o f  the
p e r io d  fo llo w in g  trea tm en t d u rin g  which the  b lood  was fre e  from trypanosomes 
(a ) /
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(a) The re lapses fo llo w in g  r e la t iv e ly  la rg e  doses, 1/15*000 g. and 
1/ 25,000 g . , occurred  on the  13th  and 8 th  days re s p e c t iv e ly  a f te r  
tre a tm e n t, w h ile  in  the  5 Mice which rece ive d  the  sm all dose o f  
1 /200,000 g . , they were observed on th e  8 th ,  13th ,  1 4 th , 1 7 th  and 
19 th  days. (b) The stage o f  in fe c t io n  a t the  tim e o f  trea tm en t does 
n o t  appear to  in f lu e n c e  the  d u ra tio n  o f  the  f re e  p e r io d ; o f  th e  3^ 
m ice ?M ch re lapsed a f te r  trea tm en t w ith  doses v a ry in g  from 1/ 30,000 g. 
to  1 /100,000 g. a t  an e a r ly  stage (Tab le  IV ) ,  2 d id  n o t respond to  th e  
drug, b u t in  29 (90 p e r ce n t.)  o f  the  rem ainder the re la p se  occurred  
between the  9 th  and 14 th  days. Of the  25 anim als which re lapsed  
fo llo w in g  trea tm en t a t th e  acme stage w ith  doses v a ry in g  from 
1/ 15,000 g. to  1/ 200,000 g . ,  17 (68 pe r ce n t.)  occurred  d u r in g  the  
same p e r io d . The o n ly  e x c e p tio n a lly  la t e  re lapse  observed was in  a 
mouse (No. 1672D) tre a te d  a t  the  acme stage w ith  1/100,000 g. Numerous 
exam inations o f  the  b lood o f  t h is  animal d u rin g  the  f i r s t  2 months were 
a l l  n e g a tive , b u t a fu r th e r  exam ination made 3 weeks la t e r  showed abundant 
trypanosomes; th e re fo re  the  re lap se  p robab ly  took p lace  a t  le a s t  2 
months a f te r  trea tm en t, c e r ta in ly  n o t d u rin g  th e  f i r s t  6 weeks when 
exam inations were fre q u e n t. D e ta ils  o f  t h is  mouse and o f  a few o th e rs  
which re lapsed , se lec ted  a t random, are g iven in  Table V.
Th is  s t r ik in g  re g u la r i t y  o f  th e  d u ra tio n  o f  the  fre e  p e r io d  i s  
fu r th e r  i l lu s t r a t e d  by a n a ly s is  o f  the re lapses fo llo w in g  tre a tm e n t a t 
th e  acme stage w ith  o th e r phenanth rid in ium  drugs, re la te d  in  chemical 
s tru c tu re  to  No. 897* Here aga in , a f te r  a d m in is tra tio n  o f  30 d i f f e r e n t  
compounds, re lapses  occurred  in  64 m ice, o f  which 45 (70 p e r  c e n t.)  took 
p la ce  between the  9 th  and 14 th  days a f te r  tre a tm e n t. Table VI shows /
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shows the  d u ra tio n  o f  the  f re e  p e r io d  in  days a f te r  d i f f e r e n t  doses o f  
No. 897 adm in is te red  to  S tra in  I  in fe c t io n s  a t  an e a r ly  stage, a t  acme, 
and a lso a f te r  o th e r  phe nan th rid in ium  drugs. From th is  ta b le  the  
rem arkable r e g u la r i t y  o f  the  re lapses  appears c le a r ly ,  and i s  seen to  
be independent o f  th e  p a r t ic u la r  drug o r  o f  a cons ide rab le  range o f  
dosage o r  stage o f  th e  in fe c t io n  a t which the  drug was adm in is te red .
Also the  few excep tions are shown in  which re lapses  were observed 
a f te r  a lo n g e r tim e.
S tra in  I I . Relapses occurred  m ostly  8 to  11 days a f te r  tre a tm e n t, 
i r r e s p e c t iv e  o f  the  dose o f  drug adm in is te red  w ith in  wide l im i t s  and the 
stage o f  in fe c t io n  a t th e  tim e o f  trea tm en t. In  4 mice — 2 tre a te d  
w ith  1 /20 ,000 g. a r e la t iv e ly  la rg e  dose, and 2 w ith  th e  sm a ll dose o f  
1/100,000 g. — the  re lapses o f  each p a ir  occu rred  on the  9 th  and 10 th  
days re s p e c t iv e ly .  Table IV  shows th a t 26 and 52 re lapses  fo llo w e d  
trea tm en t a t th e  e a r ly  and the  acme stages re s p e c t iv e ly ;  In  21 ( 8 l  p e r 
c e n t.) o f  th e  form er and 38 (73 Pe r ce n t.) o f  the  l a t t e r  the  re lap ses  
were observed between the  8 th  and 11 th  days. E x c e p tio n a lly  the  fre e  
p e r io d  was much lo n g e r — 2 re lapses  o c c u rr in g  on the  2Lst, 2 on th e  
24th , 8nd 1 on the  50th day a f te r  trea tm en t. S im ila r  d e ta i ls  to  those 
, g iven f o r  S tra in  I  are g iven f o r  S tra in  I I  in  TabLes V and V I.
From the  fo re g o in g  data  i t  may be deduced th a t  a f te r  a d m in is tra tio n  
o f  th e  drug in  an amount which i s  n o t c u ra t iv e , an im m unity develops 
which breaks down a f te r  a p e r io d , which i s  r e la t iv e ly  constan t f o r  each 
s t ra in ,  c o n s t itu t in g  a re lapse .
Treatment /
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Treatment o f  Chronic In fe c t io n s  — S tra in s  I  and I I .
In  v iew  o f  th e  d if fe re n c e  in  c u r a b i l i t y  o f  the  in fe c t io n  when tre a te d  
a t  th e  e a r ly  and acme stages, i t  appeared im p o rta n t to  de lay  trea tm en t 
u n t i l  th e  ch ron ic  stage, t h is  be ing a r b i t r a r i l y  f ix e d  a t 3 to  6 weeks- 
a f te r  the  acme fo r  S tra in  I ;  thus  tim e was g iven e ith e r  f o r  a re la p se  
to  occur o r  f o r  p a ra s ite s  to  have p e rs is te d  in  the  blood f o r  a cons ide rab le  
p e r io d . In  the  case o f  S tra in  I I ,  the  ch ron ic  stage was reckoned as 
hav ing  been reached a few days a f te r  the  acme, s ince  by then abundant 
p a ra s ite s  had been p resen t co n tin u o u s ly  in  the  b lood f o r  some tim e  and 
th e  hos t would p roba b ly  d ie  i f  l e f t  u n tre a te d . Such de lays caused s t i l l  
fu r th e r  d i f f i c u l t y  in  e f fe c t in g  cure; the  re s u lts  are g iven f o r  both  
s t ra in s  in  Table V II  under th e  heading "c h ro n ic  in  the  o r ig in a l  mouse".
I t  i s  o f  in te r e s t  to  no te  th a t  w ith  S tra in  I I ,  3 to  4 days a f te r  the  
acme stage the  c u r a b i l i t y  o f  th e  s t ra in  has a lte re d  co n s id e ra b ly . Thus 
i t  can be seen th a t  by w ith o ld in g  trea tm ent u n t i l  the ch ro n ic  stage, in  
th e  case o f  S tra in  I  a dose o f  1 /10,000 g. cured 12 m ice o u t o f  29? 
s im i la r ly  w ith  S tra in  I I  a dose o f  1 /2 ,000  g. to  1 /3 ,000  g. cured o n ly  
6 o u t o f  40 anim als.
The c o n tra d ic to ry  re s u lts  repo rte d  in  the  two e a r ly  p u b lic a t io n s  
o f  Browning e t a l .  re fe rre d  to  in  the  in tro d u c t io n  (p . 2 ), are  r e a d i ly  
exp la ined  as a r e s u l t  o f  the  above in v e s t ig a t io n s  on the  c u r a b i l i t y  o f  
th e  s tra in s  a t  v a ry in g  stages o f  in fe c t io n .  Exam ination o f  the  reco rds  
has shown th a t th e  o r ig in a l  t r i a l s  o f  the  drug on S tra in  I  in fe c t io n s  
were a l l  c a rr ie d  o u t by trea tm en t a t  the  ch ron ic  stage} thus, Browning,
Morgan, Robb and W alls  (193$) found th a t  cures were ob ta ined  w ith  doses 
approxim ating  to  th e  maximum to le ra te d . On the  o th e r  hand, the  more 
fa vo u ra b le  re s u lts  ob ta ined  by Browning, Browning and Robb (1940) wrere a l l
/
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a l l  in  an im als w ith  acute in fe c t io n s  ( e i th e r  e a r ly  o r  acme)*
In fe c t io n s  w ith  a C hronic S tra in  — S tra in s  I  and I I .
Whan the  inoculum  i s  d e rive d  from a mouse in  which the  in fe c t io n  
has become ch ro n ic , the  r e s u lt in g  in fe c t io n  due to  t h is  "c h ro n ic  s t ra in "  
i s  more d i f f i c u l t  to  cure than one from the  customary acme in fe c t io n  ( p .6 ). 
Again, the  ch ro n ic  stage has been a r b i t r a r i l y  f ix e d  as 3 to  6 weeks a f te r  
th e  acme f o r  S tra in  I  and a few days a f te r  the  acme f o r  S tra in  I I .
D e ta ils  f o r  bo th  ch ron ic  s t ra in s  are  given in  Table V I I ;  thus 1 /L0 ,000  g. 
cured 13 o u t o f  17 m ice w ith  ch ron ic  S tra in  I  in fe c t io n s ,  w h ile  
1 /2 ,000  g. to  1 /3 ,000  g. cured 14 o u t o f  22 m ice w ith  ch ron ic  S tra in  I I .
F a ilu re  to  develop in fe c t io n  when the  inoculum  i s  de rive d  from  a 
c h ro n ic a lly  in fe c te d  animal i s  common vd th  S tra in  I ,  e .g . o u t o f  149 
in o c u la te d  m ice, 41 (a lm ost 28 p e r ce n t.) f a i le d  to  become in fe c te d ;  
b u t a l l  in o c u la t io n s  w ith  ch ron ic  S tra in  I I  trypanosomes were success fu l. 
The fa i lu r e s  w ith  ch ron ic  S tra in  I  in o c u la t io n s  are  most p roba b ly  due to  
re s is ta n c e  o f  th e  in d iv id u a l h o s t, s ince  in  most o f  th e  s e r ie s  o f  
in o c u la t io n s  a t  le a s t  one animal became in fe c te d .  Th is  v a r ia t io n  in  
s u s c e p t ib i l i t y  i s  s im ila r  to  th a t  found by B inns (193^) in  in d iv id u a l 
r a ts  and ra b b its  to  in o c u la t io n  w ith  7 s tra in s  o f  T. congolense from 
in fe c te d  c a t t le .
Summary. By comparing Tables IV  and V I I  i t  can be seen th a t  the
o rd e r o f  c u r a b i l i t y  o f  the  v a rio u s  stages o f  th e  in fe c t io n  o f  bo th
s tra in s ,  s ta r t in g  w ith  the  most re a d i ly  cured, i s  as fo l lo w s : -
(a ) acme, (b) e a r ly  — *hrl, (c ) a ch ron ic  in fe c t io n  and (a) th e  c h ro n ic
stage in  the  o r ig in a l  mouse. Thus i t  has been found th a t  in  m ice the  
c u ra t iv e  dose f o r  a ch ron ic  in fe c t io n  may be a t  le a s t  5 to  10 tim es /
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t im e s  th a t  re q u ire d  a t  acme. These obse rva tions  on the  experim enta l 
tre a tm e n t o f  ch ron ic  in fe c t io n s  p robab ly  have an im p o rta n t bea rin g  on 
th e  re s u lts  under f i e l d  co n d itio n s*
P ro p h y la c t ic  Actio n .
No. 897 in  a dose o f  1 /1 ,000  g. adm in is te red  2 days be fo re  the  
in o c u la t io n ,  p ro te c te d  2 m ice a g a in s t S tra in  I .  Doses g iven 4 to  6 
days be fo re  in o c u la t io n  d id  n o t e x e rt any p ro p h y la c t ic  a c tio n , s ince  
in  each in s ta n ce  th e  trypanosomes appeared in  the  anim als under t e s t  
a t  the  same tim e  as in  the  u n tre a te d  c o n tro ls , see ta b le  below.
No. Dose o f  drug. Time be fo re  
in o c u la t io n .
R e s u lt.
I 663A lA iO O O  g. 2 days complete p ro te c t io n
I 663B 1/1 ,000  g. 2 days n ii
1664D 1 /2 ,000  g. 4 days as c o n tro l
1673A 1 /1 ,000  g. 5 days it it
1673B 1/1 ,000  g. 5 days it it
1664A 1/L ,000  g. 6 days 11 it
1664c 1 /1 ,000  g. 6 days n n
Thus o n ly  a s l ig h t  p ro p h y la c t ic  a c tio n  i s  e v id e n t; these re s u lts  are in  
c o n tra s t to  the  pro longed p ro te c t iv e  e f fe c t  o f  Bayer 205 c e r ta in  
benzoylamino q u in o lin e  s ty r y l  compounds a g a in s t T. b ruce i (B rowning and 
Gulbransen, 1934)* In  f i e l d  t r i a l s  Carmichael and B e ll (1944^) found 
th a t  No. 897 p ro te c te d  c a t t le  a g a in s t T. congolense in fe c t io n  up to
48 hours a f te r  a d m in is tra tio n  (s e c tio n  V I I ) .
O ra l A d m in is tra ti on o f  No. 897*
D a ily  feed ing  w ith  bread soaked w ith  1 c. c. o f  1/1,000 s o lu t io n  o f  
No. 897 was given in  p la ce  o f  normal d ie t  to  6 m ice f o r  11 days. On th e  
1 1 th  day the  mice were in fe c te d  w ith  S tra in  I ,  and fe e d in g  w ith  the  drug 
was continued f o r  a fu r th e r  7 days, d u rin g  which tim e the  tiypanosomes
-  18 -
trypanosomes developed as in  th e  c o n tro ls . By t h is  tim e  th e  in fe c t io n  
was a t  the  acme stage; a subcutaneous dose o f  l / 30>000 g. was g iven 
to  each and fe e d in g  vd th  the  drug d isco n tin u e d ; 4 o u t o f  th e  6 m ice 
were cured. Drug fe e d in g  as above was in s t i t u t e d  in  6 m ice in fe c te d  
w ith  S tra in  I  when trypano somes were in  scanty numbers in  the  b lood and 
continued f o r  7 days, d u rin g  which tim e the  course o f  th e  trypano some 
in fe c t io n  progressed through the  acme to  the  re lap se  stage as in  the  
c o n tro ls .  Thus th e re  i s  no evidence th a t  abso rp tio n  o f  the  drug in  an 
a c t iv e  form  takes p lace  from the  a lim en ta ry  t r a c t ,  s ince  No. 897 on 
o r a l a d m in is tra tio n  e x e rts  n e ith e r  p ro p h y la c t ic  n o r c u ra t iv e  a c tio n .
SECTION III
TREATMENT WITH OTHER DHTGS.
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P henan th rid in ium  S e rie s .
The fo re g o in g  ta b le  g ives a l i s t  o f  the  compounds and the  re s u lts  
o b ta in e d . I t  can be seen th a t  the  g re a te s t th e ra p e u tic  a c t iv i t y  
a g a in s t T. congolense S tra in  I  in fe c t io n s  i s  exerted  by compounds w ith  
2 amino s u b s titu e n ts , s itu a te d  e ith e r  bo th  in  the  phenanthrene nuc leus 
o r  one in  th e  l a t t e r  and the  o th e r in  th e  benzene nuc leus, e. g,
compounds 1565 (1 9 ); 1553 (20)• 1542 (45) ;  897 ( 2) ;  1551 ( 3) ;  1552 (4);
1570 ( 5 ) :  1508 (1 0 ); 1568 (1 1 ): 894 (38) and 1573 ( 43) .  Compound
1141 ( 46) which has a bromine atom in  the  3 p la c e , w ith  amino groups 
as in  897, i s  in f e r io r  to  the  l a t t e r .  A l l  these compounds are o f  
cons ide rab le  th e ra p e u tic  a c t iv i t y .  A cco rd ing ly , a v a r ie ty  o f  p o s it io n s  
o f  the  amino groups i s  a pp a ren tly  a m a tte r o f  com parative in d if fe re n c e  
so f a r  as th e ra p e u tic  a c tio n  i s  concerned. Two amino groups bo th  in  
the  benzene r in g  in  the  m p o s it io n s  are n o t assoc ia ted  vd th  a c t iv i t y  
(No. 1052 (2 8 ) ) .  A s in g le  amino group s itu a te d  in  e i th e r  nuc leus 
in c reases  the  toxLcd ty  and reduces cons ide rab ly  o r  destroys th e  th e ra p e u tic  
a c t io n , e .g . Nos. 206 (3 2 ); 207 (3 0 ); 208 (2 3 ); 621 (2 4 ): I 505 (15)
and I 506 (1 6 ). Much la rg e r  doses o f  the  a e e ty la te d  d e r iv a t iv e s  than 
o f  the  corresponding amino compounds are as a r u le  w e ll to le ra te d ,  bu t 
l i t t l e  o r  no a c t iv i t y  aga ins t th e  in fe c t io n  i s  m an ifes ted , e .g . 8 9 6 (1 ) ;
897 ( 2) ;  1507 (9)5 1508 (10) ;  1504 (1 4 ); 1505 (15) ;  1555 (18) ;  1554 (17) ;  
1565 (1 9 ): 1162 ( 33)5 1542 ( 34) ;  893 ( 3^)5 894 ( 38) ;  1574 (4 2 ); 1573 ( 43);
1142 (45) and 1141 (4 6 ).
The i r r i t a t i n g  e f fe c t  o f  th e  drug on the  t is s u e s  a t th e  s i t e  o f  
in je c t io n  i s  an im p o rta n t p ro p e rty . No. 1553 i s  ou ts ta n d in g  on account 
o f  i t s  r e la t iv e  la c k  o f  i r r i t a t i n g  a c tio n  in  comparison w ith  i t s  
th e ra p e u tic  e f f ic ie n c y .
*
(The numbers in  b racke ts  are the  s e r ia l numbers in  the  ta b le ) .
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P h enan th rid ine  compounds. The p h e n a n th rid in e  compound No. 892 
(maximum to le ra te d  dose I /250 g . ) ,  correspond ing to  No. 894 (3 $ ) ; 8oa^  
No. 895 (maximum to le ra te d  dose 1 /2 ,500  g . ) ,  correspond ing to  No.
897 ( 2) ,  are bo th  w ith o u t th e ra p e u tic  a c tio n  on acme in fe c t io n s  w ith  
S tra in  I .
P i ami  d ine Serie s .
The compound 4 :4 *-d ia m id in o  s t ilb e n e  was shown by L o u r ie  and 
Yoike (1939) to  be c u ra t iv e  in  maximum to le ra te d  doses a g a in s t 
T. consolense in fe c t io n s  in  m ice. A compound o f  t h is  c la ss , 
4: 4f -d ia m id in o  d im e thy l s t ilb e n e , more e f fe c t iv e  aga ins t the  same 
p a ra s ite  was described by P u lton  and Yorke (1942). In  1943 the  sane 
au thors compared the  l a t t e r  compound w ith  No. 897> both  be ing  given 
subcutaneously, and considered i t  to  be " a t  le a s t  as a fctive  c u ra t iv e ly  
a g a in s t ou r s t ra in  o f  T. congolense in fe c t io n s  in  m ice ". The p re se n t 
au tho r w orking w ith  la b o ra to x y  S tra in  I  in fe c t io n s  a t  acme in  m ice, 
accord ing  to  the methods described in  the te x t ,  has found th a t  
4 : 4 , -d ia m id in o  d im e thy l s t ilb e n e  in  a dose o f  1/ 5,000 g. cured 21 o u t 
o f  24 (87.5  p e r cent)., w h ile  under the  same c o n d itio n s  No. 897 i *1 & 
dose o f  1/ 75,000 g. cured 11 o u t o f  15 ( 73*3 c e n t.)  and l / L 00,000 g. 
cured 14 o u t o f  26 (54 pe r c e n t . ) ;  the maximum to le ra te d  doses are 
1/500  g. and 1 /1 ,000  g. re s p e c t iv e ly .  A cco rd in g ly , the  statem ent o f
5 \ilto n  and Yorke does n o t ho ld  under these c o n d it io n s , s ince  1 /7 5  °£ 
th e  to le ra te d  dose o f  No. 897 has about the  same c u ra t iv e  a c tio n  as 
1 /L0  o f  the  to le ra te d  dose o f  th e 'd im e th y l s t i lb e n e  drug. In  ch ron ic  
in fe c t io n s ,  however, th e  d im ethy l s t ilb e n e  compound appears to  be
alm ost as e f fe c t iv e  as a t acme. Therefore  i t  i s  p o s s ib le  th a t  t h e i r  
obse rva tions  were made on such in fe c t io n s .
- 24 -
QLiindo l in e  M ethoch lo ride  ( I .C . I . ) ? *
T h is  compound in  doses approaching th'e maximum to le ra te d  (1 /750 £• 
cured 9 o u t o f  10 m ice. The ve ry  severe lo c a l n e c ro t ic  a c tio n  a t  
th e  s i t e  o f  subcutaneous in je c t io n  a lm ost p rec ludes  i t s  use.
The correspond ing h yd ro c h lo r id e  ( I . C . I . ) ,  (maximum to le ra te d  
dose 1/200 g .)  i s  w ith o u t th e ra p e u tic  a c tio n  in  a dose o f  1/250 g.
^  I  am indeb ted  to  Im p e r ia l Chemical In d u s tr ie s ,  Manchester, f o r  
th e  supply o f  t h is  drug and o th e rs  marked I . C . I .
SECTION IV .
TREATMENT OF RELAPSES.
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S tra in  I I  Relapses.
I t  has been noted th a t  a marked th e ra p e u tic  response occu rred  to
s u b -c u ra tiv e  doses o f  No. 897, and th a t  t h is  was w ith in  w ide l im i t s
independent o f  the  amount o f  the  drug and o f  the  degree o f  in fe c t io n
as measured by the  number o f  p a ra s ite s  in  the  b lood a t th e  tim e o f
trea tm en t (see Tables IV  and V I) .  A cco rd in g ly , i t  was decided to
t r e a t  a l l  re lapses o f  S tra in  I I  in fe c t io n s  w ith  a s in g le  dose o f
1/15 ,000 g. T h is  amount cures 38 pe r cen t, o f  the  in fe c t io n s  a t acme,
b u t few i f  any a t an e a r l ie r  stage (see Table IV ) .  W ith  t h is  dose
in  anim als which had re lapsed  f o r  the  f i r s t  tim e, a ve ry  d e f in i t e
th e ra p e u tic  e f fe c t  was observed, the b lood in v a r ia b ly  becoming fre e
o f  trypano somes f o r  a p e r io d , w h ile  in  a sm all p ro p o rt io n  o f  cases
complete s t e r i l i s a t io n  re s u lte d . The re fo re , i t  appeared d e s ira b le  to
t r e a t  successive re lapses , each w ith  a s in g le  dose o f  l/L 5 ,0 0 0  g . ,
ir r e s p e c t iv e  o f  the  i n i t i a l  dosage. Almost a l l  the  re lap ses  were
tre a te d  im m ed ia te ly  the  trypanosomes became abundant, b u t o c c a s io n a lly
the  drug was adm in is te red  a t  an e a r l ie r  stage o f  the  re la p se . A
fe a tu re  o f  the  experiment was th a t  most o f  the  mice k e p t in  good
c o n d it io n  th roughou tj o n ly  o c c a s io n a lly  was th e re  a s l ig h t  lo s s  o f
h a ir  from the  back a t the  s i te  o f  in je c t io n  o f  the  drug, bu t the re
was never any n e c ro s is . Owing to  the  repeated ta il-e x a m in a t io n s , 3
m ice ( 758B, 765B and 75$A) had to  be ch loro form ed a f te r  the  1 1 th , 13th
and 14 th  re lapses re s p e c t iv e ly ,  because n e c ro s is  o f  the  t a i l  made fu r th e r
exam inations im poss ib le . These animals were e x ce p tio n a l, as the  t a i l s
o f  a l l  th e  o the rs  w ith s too d  the repeated h a n d ling , e .g . the  t a i l  b lood 
o f  mouse 76IA  was examined 187 tim es in  a lm ost 13^ months.
Cure /
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Cure fre q u e n t ly  re s u lte d  from  repeated tre a tm e n ts , and u s u a lly  
w ith in  6 re tre a tm e n ts ; h u t one animal ( 760A) was cured a f te r  the  
21s t  and 2 ( 590A d e f in i t e ly  and 593® probab ly) were cured a f te r  20 
re lap ses  — 12, 9§ and 7 months re s p e c t iv e ly  a f te r  the  o r ig in a l  
tre a tm e n t. In  mouse jSlk response to  trea tm en t o f  29 re lapses  was 
ob ta ined  ove r a p e r io d  o f  1 yea r, the  g re a te s t number tre a te d ; b u t 
cure was n o t e ffe c te d . Table V I I I  summarises the  trea tm en ts  o f
re lapses  and re s u lts .  Of the  56 re lapsed an im a ls, some tre a te d
i n i t i a l l y  w ith  doses g re a te r than and some w ith  doses le s s  than 
1/ 15,000 g . , 23 were cured a f te r  a number o f  re lapses  v a ry in g  from 
1 to  21; o f  th e  re s t  20 d ied  in  t e r  c u r re n t ly  and the  rem ain ing 13 
were chloro form ed f o r  va rio u s  reasons. The stage o f  in fe c t io n  a t  the  
i n i t i a l  trea tm ent o r  the  dose o f  drug given a t  th a t tim e  do n o t seen 
to  in f lu e n c e  the  re s u lts  o f  re tre a tm e n ts . I t  i s  in te r e s t in g  to  no te  
th a t  in  2 in s ta n ce s  the  1s t  re lapse  was cured by a sm a lle r dose than 
fa i le d  i n i t i a l l y ,  e .g . 586® and 589®* which rece ive d  o r ig in a l ly  
1/ 5,000 g. and 1/ 10,000 g. re s p e c t iv e ly .
I t  i s  a s t r ik in g  O bservation th a t  w ith  S tra in  I I  the  chance o f
cure under repeated trea tm en t o f  re lapses i s  p r a c t ic a l ly  the  same as
th e  chance o f  cure o f  the  o r ig in a l in fe c t io n ,  s ince  w ith  an i n i t i a l
dose o f  1/ 15>000 g. o r  over a t the  acme stage 23 o u t o f  60 (38 p e r
c e n t.)  were cured, w h ile  14 (11 d e f in i t e ly  and 3 most p robab ly) o u t
o f  37 (38 p e r c e n t.)  were cured a f te r  a number o f  re tre a tm e n ts . T h is
i s  c o n tra ry  to  the  w id e ly  accepted b e l ie f  based on o bse rva tions , w ith
o th e r  species o f  trypanosomes, th a t in fe c t io n s  are most re a d i ly  cured
by v igo rous  i n i t i a l  trea tm en t, w h ile  the  cure o f  re lapses p resen ts  
e sp e c ia l d i f f i c u l t i e s .
One /
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One o f  the  s a l ie n t  fe a tu re s  o f  the  trea tm en t o f  re la p se s  in  S tra in  
I I  w ith  a dose o f  l/L 5 ,0 0 0  g. i s  the  r e g u la r i t y  w ith  which successive 
re la p se s  occurred  and the  immediate response to  the  drug a t  each 
tre a tm e n t. As has been shorn p re v io u s ly  (p . 1 4 ) ,  a lm ost a l l  the  f i r s t  
re lap ses  occurred  from the  8 th  to  the  11th  day a f te r  tre a tm e n t; and 
subsequent re lapses u s u a lly  took p lace  a t  re g u la r  in te r v a ls  o f  from 
10 to  16 days a f te r  the  p re v io u s  trea tm en t, ir r e s p e c t iv e  o f  whether o r  
n o t cure u l t im a te ly  re s u lte d ; these are considered normal re lapses.
The in te r v a l  between re lapses  may be co n ve n ie n tly  reckoned as the  
number o f  days between successive trea tm en ts . Mouse 590A a f te r  
i n i t i a l  trea tm en t w ith  1/15*000 g. No. 897 be fo re  the  acme stage, was 
cured a f te r  trea tm en t o f  th e  20t h  re lap se ; the  in te r v a ls  between 
re lapses were as fo l lo w s : -  9* 12, 11* 19* 16, 14, 17* 14, 14, 16, 12,
16, 15, 13, 15, 13* 12, 14, .11, and 14 days.
A lo n g e r in te r v a l between re lapses was observed in  13 o f  the  m ice; 
d e ta i ls  are given in  Table IX . Mouse 730A i s  no tew orthy in  th a t  6 o f  
th e  12 re lapses  were la te .  W ith  mouse 7&1® the  f i r s t  re lap se  occurred  
50 days a f te r  the  i n i t i a l  trea tm en t; i t  was re tre a te d  6 days la t e r ,  
a lthough  the  numbers o f  trypano somes in  the  b lood had n o t increased  
beyond + . D e ta ils  o f  the  exam ination o f  the  hLood have a lrea dy  been 
g iven (Tab le  V). Four fu r th e r  normal re lap ses  occurred ; and as no 
p a ra s ite s  were de tected  in  exam inations o f  the  bLood in  th e  6 weeks 
fo llo w in g  trea tm ent o f  the  5bh re lap se , the  mouse was presumed to  be 
cured. But the  6th  re lap se  was noted in  th e  course o f  ro u t in e  m onthly 
exam inations; a c c o rd in g ly , t h is  re lap se  must have occu rred  more than
89 days a f te r  the  p rev io us  re tre a tm e n t. In  3 mice (633A, 738A and 6L3B) 
trypanosomes appeared in  sm all numbers in  the  bLood a t  the  5th ,  10th  and /
and 15t h  re lapses re s p e c t iv e ly ,  and then disappeared spontaneously 
seve ra l tim es w ith o u t becoming abundant. Th is  ve ry  p ro tra c te d  type  o f  
re la p se  was considered excep tiona l and no a ttem pts were made to  t r e a t  i t .
Repeated trea tm en t w ith  s u b -c u ra tiv e  doses o f  drug i s  one method 
o f  p roduc ing  acqu ired  d ru g -re s is ta n c e  (see se c tio n  V ); thus, in  these 
experim ents evidence o f  t h is  c o n d itio n  m igh t have been expected. O nly 
in  2 m ice o u t o f  th e  47 which rece ived  3 o r  more fre treatm ents were 
th e re  any in d ic a t io n s  o f  a s l ig h t  re s is ta n c e  to  the  drug, in  so f a r  as 
re la p se s  f a i le d  to  respond to  fu r th e r  trea tm en t. The d e ta i ls  are as 
fo l lo w s : -  mouse fSlk a f te r  29 normal re lap ses , d id  n o t respond to  the  
31s t  trea tm en t —  3 more doses were then given in  th e  course o f  the  
n e x t few days, bu t w ith o u t r e s u lt .  F u rth e r work on the  behaviour o f  
the  p a ra s ite s  from th is  mouse i s  g iven la t e r  (see se c tio n  V and Table 
XV). A lso , re s is ta n c e  to  the drug appeared in  the  case o f  mouse 685A; 
a f te r  normal responses to  re trea tm en ts  the  in fe c t io n  fa i le d  to  respond 
to  th e  trea tm ent o f  th e  14 th  re lapse .
Treatment o f  Relapses w ith  Doses O ther Than 1 A 5 .0 0 0  g.
F a ilu re  to  cure in fe c t io n s  w ith  S tra in  I I  a t  th e  acme stage by doses 
o f  the  drug g re a te r than l/L0 ,Q 00  g. are unusual (see Table IV ) .  Two 
such e xce p tio n a l re lapses  in  745A and 795A, fo llo w in g  1 /3 ,000  g. and 
1/ 5,000 g. re s p e c t iv e ly ,  were both  cured a f te r  3 re lap ses  which had been 
tre a te d  by a d m in is te r in g  on each occasion the  same doses as i n i t i a l l y  
when p a ra s ite s  were abundant in  the  b lood. In  s p ite  o f  the  r e la t iv e ly  
la rg e  doses, the  re la p s in g  in fe c t io n s  in  these two m ice ran a course 
ve ry  s im ila r  to  those in  the anim als described in  the  p re v io u s  s e c tio n , 
as th e  in te r v a ls  between the  re lapses were 13, 18, and 31 days in  the  
fo rm er and 13, 23 and 14 in  the  la t t e r .  Another mouse (784A) was /
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was tre a te d  a t  th e  acme stage o r ig in a l ly  and f o r  the  1 s t  9 re la p se s  
w ith  a dose o f  1/130*030 g. th roughou t, then fo r  the  10t h  to  13th  
re lap ses  w ith  1/ 50,000 g . ; and was f i n a l l y  cured a f te r  t r e a t in g  th e  
1 4 th  re lap se  w ith  1 /3 ,000  g.
T he re fo re , as f a r  as S tra in  I I  i s  concerned, th e re  i s  no reason 
to  desp a ir o f  c u r in g  an in fe c te d  animal when the  i n i t i a l  dose has 
f a i le d ;  success may r e s u lt  a f te r  a number o f  re tre a tm e n ts . These 
experim ents are  s im ila r  to  those c a rr ie d  o u t by Browning and 
Gulbransen (1928) w ith  T. b ru ce i in  m ice, in  which s t e r i l i s a t io n  was 
ob ta in e d  a f te r  v a ry in g  numbers o f  re tre a tm e n ts , w ith  a dose o f  a 
s t y r y l  compound which had f a i le d  to  cure the  o r ig in a l  in fe c t io n  and 
e a r l ie r  re lapses .
S tra in  I  Relapses.
S im ila r  trea tm en t o f  re lapses in  S tra in  I  in fe c t io n s  was c a r r ie d  
o u t. Doses o f  1 /75,000 g. to  1/L00,000 g. f o r  t h is  s t ra in  were 
considered jto correspond in  th e ra p e u tic  e f f ic a c y  w ith  a dose o f  
l / L 5,000 g. f o r  S tra in  I I  (Tab le  IV ) .  A cco rd in g ly , re lap sed  mice 
which had been tre a te d  a t  the  acme stage, one w ith  1/ 75*000 g. and
5 w ith  1/ 100,000 g . , were tre a te d  im m ed ia te ly  the  p a ra s ite s  became 
abundant, the  same dose o f  No. 897 be ing used as th a t  g iven i n i t i a l l y ;  
i n  each case th e re  was a d e f in i te  th e ra p e u tic  e f fe c t .  S im ila r  tre a tm e n t 
was given f o r  the  2nd re lap se ; o n ly  in  4 o f  the  6 anim als was th e re  
a d e f in i t e  response, 1 being cured; o f  the  rem ain ing 2 anim als one d id  
n o t respond to  the  drug and the  o th e r o n ly  very s l ig h t ly .  Table X
g ive s  d e ta i ls .  Where o n ly  a s l ig h t  response to  the  drug, o r  none, 
occu rred , the  n e x t trea tm en t was given ’w ith in  a week.
D e f in ite  /
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D e f in ite  in d ic a t io n s  o f  re s is ta n c e  to  tre a tm e n t were no ted  in  
4 m ice, from 3 weeks to  2 months a f te r  th e  i n i t i a l  tre a tm e n t — in  
2 anim als a f te r  the  3rd  tre a tm e n t and in  the  o th e rs  a f te r  the  4 th  and 
6th  trea tm en ts  re s p e c t iv e ly ;  these are u n d e r lin e d  in  the  ta b le .
The dose o f  th e  drug f o r  each trea tm en t in  m ice I 56IA  and I 56IB  was 
increased  to  1/ 3,000 g. a t the  6th  and 8 th  trea tm en ts  re s p e c t iv e ly ;  
in  the  fo rm er the  6th  to  th e  11th  trea tm en ts  o n ly  produced a s l ig h t  
response, b u t in  the  l a t t e r  cons ide rab le  a c tio n  was observed fo llo w in g  
th e  8 th  to  th e  11th  trea tm en ts ; however, th e re  was no response to  
the  12th  tre a tm e n t in  e i th e r  animal o r  to  subsequent trea tm en ts  in  
I 56IA  (ow ing to  i t s  c o n d itio n  I 56LB cou ld  n o t be tre a te d  fu r th e r)#  
In fe c t io n s  de rive d  from these 2 m ice were tre a te d  in  fre s h  an im als;
Table XE g ives d e ta i ls .  The b lood used f o r  in fe c t in g  the  f re s h  anim als 
was w ithdrawn im m edia te ly be fo re  the  in fe c t io n  was tre a te d  in  the  p a ren t 
mouse, consequently a l l  th e  drug had been e lim in a te d . The p a ra s ite s  
showed more response to  the  drug in  fre s h  hosts  than in  the  o r ig in a l ,  
b u t in  most the  th e ra p e u tic  a c tio n  d isappeared a f te r  a few re tre a tm e n ts . 
O cca s io n a lly , a f te r  o n ly  s l ig h t  responses to  severa l consecu tive  
trea tm en ts , subsequent tre a tn e n ts  produced a d e f in i te  response (e .g . 
mouse I 623B). I t  m igh t appear from the  above obse rva tions  th a t  in  
t h is  s t ra in  d ru g -re s is ta n ce  to  No. 897 cou ld  be re a d ily  developed; 
t h is ,  however, proved to  be extrem ely d i f f i c u l t  (s e c tio n  V).
The experim ents on repeated trea tm en t o f  re lapses in  S tra in  I  
in fe c t io n s  were d iscon tinu ed , as the  re s u lts  recorded above were n o t 
encouraging qua u lt im a te  c u r a b i l i t y .  Thus 4 o u t o f  the  6 anim als f a i le d  
to  respond a f te r  a few re trea tm en ts , w h ile  t h is  o n ly  occurred  in  2 o u t /
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o u t o f  56 anim als w ith  S tra in  I I ,  the  e a r l ie r  be ing  a f te r  14 re la p se s .
Thus i t  appears th a t  once a degree o f  re s is ta n c e  to  tre a tm e n t w ith  
th e  drug has been m an ifes ted , no g re a te r response m i l  r e s u l t  from  
fu r th e r  repeated trea tm en t even in  doses approx im ating  to  th e  maximum 
to le ra te d .  Moreover, on passage o f  the  trypano somes to  a fre s h  hos t 
t h is  re s is ta n c e  i s  m ain ta ined  on about th e  same le v e l;  b u t i t  i s  n o t 
in c rea sed  by fu r th e r  trea tm en ts  and passages; consequently a ty p ic a l 
d ru g - re s is ta n t s t ra in  has n o t been produced. These f in d in g s  are
most p robab ly  due to  the  ch ron ic  ch a rac te r o f  th e  in fe c t io n ,  which i s  
s im ila r  to  a c o n d it io n  encountered in  f ie l d  work in  the  tre a tm e n t o f  
re lapses  in  c a t t le  in fe c te d  w ith  T. congolense (s e c tio n  V I I ) .
D iscussion
There appears to  be no s im ple exp lana tion  o f  the  above o b se rva tio n s  
on the  trea tm en t o f  re lapses , s ince  v a r ia b le  fa c to rs  on the  p a r t  bo th
o f  the  h os t and th e  trypano somes may be in v o lv e d ; such are (1 ) the
power o f  th e  hos t to  produce an tibody , ( 2) th e  a b i l i t y  o f  th e  p a ra s ite s  
to  adapt themselves to  the  serum a n tib o d ie s , ( 3) the  c u r a b i l i t y  o f  
re lapse  (c h ro n ic ) s tra in s  and (4) the  development o f  d ru g - re s is t  an t 
s tra in s .  I t  i s  remarkable th a t  re lapsed in fe c t io n s  w ith  S tra in  I I  
should respond b e t te r  to  trea tm en t than those w ith  S tra in  I  in  v iew  
o f  2 fa c ts ,  v iz .  (a) S tra in  I  trypano somes are  more re a d ily  in flu e n c e d
by the  drug than those o f  S tra in  I I  bo th  a t acme and a t  the  ch ro n ic
(re la p se ) stage and (b) the  im m unity fo llo w in g  cure o f  S tra in  I  
in fe c t io n s  i s  much more " s o l id ”  than i s  the  case f o r  S tra in  I I .
As i s  shown la t e r  (s e c tio n  V I) ,  fo llo w in g  the  cure o f  a S tra in  I  
in fe c t io n  a t th e  acme stage the  hos t in v a r ia b ly  r e s is ts  fu r th e r  
in o c u la t io n  w ith  the  homologous organisms a t the  same stage, presumably
presum ably owing to  the  development o f  a n tib o d ie s , w h ile  o n ly  about 
50 p e r cen t, o f  the  cured m ice o r ig in a l ly  in fe c te d  w ith  S tra in  I I  
m a n ife s t im m unity to  the  homologous s t ra in .  On the  o th e r  hand, s ince  
th e  re lap se  trypanosomes o f  S tra in  I  develop in  the presence o f  b lood 
and body f lu id s  which have most p robab ly  a r e la t iv e ly  e f fe c t iv e  
a n tib ody  con ten t, i t  appears l i k e l y  th a t  the  p a ra s ite s  o f  each re lap se  
may be le s s  re a d i ly  in flu e n c e d  by the  drug than those o f  a p rev io us  
re la p se  owing to  th e  p a ra s ite s  being "s e ru m -fa s t" , i . e .  r e s is ta n t  to  
the  a n tib o d ie s , whereas the  re lapse  p a ra s ite s  in  the  case o f  t re a te d  
S tra in  I I  in fe c t io n s  develop in  a serum which does n o t con ta in  such 
e f fe c t iv e  a n tib o d ie s , thus each re lapse  i s  in flu e n c e d  by fu r th e r  
trea tm en t to  about the  same degree as the  p rev io us  one.
In  the  fo llo w in g  se c tio n  i t  w i l l  be shown th a t  in  s p ite  o f  
re s is ta n c e  to  re tre a tm e n t o f  re lapses no ted  in  the  case o f  c e r ta in  
anim als w ith  S tra in  I I  and commonly in  the  case o f  S tra in  I ,  d i f f i c u l t y  
was experienced w ith  bo th  s t ra in s  in  a ttem pts  to  produce d ru g - re s is ta n t  
organism s.
SECTION V.
ATTEMPTS TO DEVELOP STRAINS OF T. CONGOLENSE 
RESISTANT TO DRUG NO.897.
Attempts to Develop Strains of T. Congolense Resistant to Drug No, 897.
Experimental in v e s tig a tio n s  on the development o f  d ru g -re s is ta n t 
s tra in s  o f  T. congolense have no t h ith e r to  been p o ss ib le , as no e f f ic ie n t  
drug was a va ila b le  to  s te r i l is e  in fe c tio n s  v .ith  th is  species o f  trypanosome. 
However, in  the course o f  examining the b io lo g ic a l p ro p e rtie s  o f  compound 
No, 897 attempts have been made to develop s tra in s  in  mice o f  T. congolense 
re s is ta n t to  the drug.
Since Franke and Roehl (see E h r lic h  19.07) f i r s t  recorded th e ir  
observations on .acquired drug-re  s i stance, s tra in s  o f  T. brucei and 
T. r hodesiense re s is ta n t to almost every type o f  trypanoc ida l agent 
have been described. The o r ig in a l method was to  t re a t  in fe c te d  mice 
by feeding w ith  the drug (para fuchsin) in  doses which banished the 
p a ra s ite s  from the blood fo r  a tim e. The trypano somes o f the re lapse 
were trea ted  s im ila r ly ;  th is  procedure was repeated u n t i l  no the rapeu tic  
response resu lted  from feeding w ith  the drug. The trypano somes were 
then tra n s fe rre d  to  a fresh  host and i f  the drug exerted a the rapeu tic  
e ffe c t in  the new mouse the treatm ents were continued. In  th is  way 
a f te r  treatment in  successive passages a d ru g -re s is ta n t s tra in  re su lte d , 
which was also a relapse s tra in  as regards i t s  se ro lo g ica l and 
immunological p ro p e rtie s . The same re s u lt  m ight be got by a dm in is tra tion  
o f  the drug suhcutaneou&Ly. R esis tan t s tra in s  s e ro lo g ic a lly  id e n t ic a l
w ith  the parent s tra in s  are obtained by tre a tin g  inocu la ted  mice a t a. 
tim e when, the in fe c t io n  i s  developing and the trypano somes are scanty in  
the  blood, w ith  a dose o f the drug which does no t a f fe c t  the course o f 
the  in fe c t io n ; the pa ras ites  are then tra n s fe rre d  a t the acme stage 
to a fre sh  host, In  successive passages the dose o f  the drug which /
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which f a i l s  to  produce a th e ra p e u tic  e f fe c t ,  i s  g ra d u a lly  increased  
u n t i l  maximum re s is ta n c e  i s  ob ta ined . Yorke e t e l .  (1931) have 
described  another method o f  o b ta in in g  a r e s is ta n t  s t ra in ,  which they 
c la im  g ives ra p id  r e s u lts .  The trypano somes a f te r  exposure in  v i t r o  
to  th e  a c t iv e  drug, e .g . reduced trypa rsam ide , a re  washed and in je c te d  
in to  m ice; when th e  in fe c t io n  develops th is  procedure i s  repeated in  
a s e r ie s  o f  passages w ith  in c re a s in g  co nce n tra tio ns  o f  the  drug, u n t i l  
maximum re s is ta n c e  i s  ob ta ined .
S tra in  I .
The f i r s t  a ttem p t to  develop re s is ta n c e  to  No. 897 fo llo w e d  the  
method o f  t re a t in g  re lap ses . Evidence o f  s l ig h t ly  in c reased  re s is ta n c e  
appeared in  a mouse (No. I 528A) in fe c te d  w ith  S tra in  I ,  which re lapsed  
a f te r  trea tm en t w ith  l/75>000 g. g iven a t  acme. The same dose was 
repeated when the  trypanosomes o f  the  1 s t  and 2nd re lap ses  became 
abundant. The 3rd  trea tm en t had no th e ra p e u tic  e f fe c t ,  n e ith e r  had 
a 4 th  and a 5th .  A f te r  the  5t h  trea tm en t the  trypanosomes were 
t ra n s fe r re d  to  fre s h  m ice which were tre a te d  s im i la r ly .  D e ta ils  o f  
the  trea tm en ts  and passages are given in  Table X I I ;  s l l  i n i t i a l  
trea tm en ts  were given a t  th e  acme stage, and the repeated doses when 
the  p a ra s ite s  were abundant in  the  blood. Fresh anim als were in o c u la te d  
when th e  p a ra s ite s  were abundant in  s p ite  o f  such tre a tm e n t. D uring 
a p e r io d  o f  6 months the  dose o f  the  drug was increased  from 1/ 75,000 g. 
to  1 /10 ,000 g. in  20 trea tm ents  ove r 12 passages. In  passage 13 however, 
th e  s t ra in  was lo s t ,  as one mouse d ied  in  t e r  c u r re n t ly  and. the  in fe c t io n  
f a i le d  to  develop in  the  second. I t  does n o t appear th a t  any g rea t 
degree o f  re s is ta n ce  was acqu ired, e s p e c ia lly  in  v iew  o f  the  fa c t  th a t  /
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th a t  in  the  course o f  the  trea tm en ts  a re lapse  (c h ro n ic )  s t ra in  was 
developed, which accord ing  to  my obse rva tio n s  (p . 16 ) would n o t be 
m arked ly in flu e n c e d  in  v ivo  by a dose o f  1 /10 ,000 g. (Tab le  V I I ) .
Another unsuccessfu l a ttem pt was made to  develop a s t ra in  o f  
T. congolense I  r e s is ta n t  to  No. 897> th is  tim e w ith  the  s e ro lo g ic a l 
and im m unologica l p ro p e r t ie s  o f  the  p a re n t s t ra in ,  by t re a t in g  the  
in fe c te d  m ice as soon as the  p a ra s ite s  were p resen t in  the  H ood in  
scanty numbers, w ith  doses which d id  n o t in f lu e n c e  the  course o f  th e  
in fe c t io n .  Then when the  acme stage was reached, the  in fe c t io n  was 
t ra n s fe r re d  to  f re s h  hosts . T h is  procedure was fo llo w e d  in  each 
passage; the  amount o f  drug was g ra d u a lly  increased  in  successive 
passages, care be ing  taken to  a d ju s t the  dosage so th a t  no d im in u tio n  
in  the  numbers o f  trypanosomes re s u lte d  in  the tre a te d  anim als, as 
compared w ith  the  numbers in  the  u n tre a te d  c o n tro ls ; e .g . in  passage 
3 , a dose o f  l / l 50>000 g. le d  o n ly  to  a ve ry  slow in c re a se  in  the  
numbers o f  p a ra s ite s , w h ile  in  a second animal o f  th e  same passage 
a f te r  a dose o f  1/ 200,000 g. the  trypanosomes increased  to  the  acme 
as ra p id ly  as in  th e  u n tre a te d  c o n tro l;  th e re fo re  the  passage was made 
from the  second anim al. In  16 passages over a p e r io d  o f  4 months 
th e  drug was increased  from 1/200,000 g. to  1 /50 ,000 g . , see Table X I I I .  
U n fo rtu n a te ly , none o f  the  3  m ice o f  passage 17 became in fe c te d ;  
however, the  r e s u lt  so fa r  as i t  went was d is a p p o in tin g  qua the  
development o f  d ru g -re s i stance.
S tra in  I I .
The method o f  g ra d u a lly  in c re a s in g  doses in  each passage was a lso
fo llo w e d  w ith  S tra in  I I ,  the doses used being those which ju s t  f a i le d  to  
slow down the  course o f  the in fe c t io n .  Over a p e r io d  o f  8 months the
/
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th e  s t ra in  was passed 34 tim es and th e  dose o f  the  drug inc reased  
from 1/750,000 g. to  1/60,000 g . , see Table XIV. A t the  3 ^ s t passage 
th e  s t ra in  was te s te d  in  p a r a l le l  w ith  th e  o r ig in a l  s t ra in  a g a in s t a 
dose o f  No. 897 which has a d is t in c t  th e ra p e u tic  e f fe c t  on the  pa ren t 
s t r a in ;  two m ice in fe c te d  w ith  the  supposedly re s is ta n t  s t ra in  and 
two in fe c te d  w ith  the  p a re n t s t ra in  each re ce ive d  a t acme l/L 0 0 ,0 0 0  g. 
No. 897. A th e ra p e u tic  e f fe c t  was observed, the  b lood  from a l l  fo u r  
be ing  fre e  o f  trypanosomes 3 days a f te r  trea tm en t. No s ig n i f ic a n t  
d if fe re n c e  in  the  sen s itive n e ss  o f  the two s t ra in s  was de tec ted , as 
re lap ses  occurred  on the  6th  and 8 th  days a f te r  trea tm en t in  th e  m ice 
in fe c te d  w ith  the  supposedly re s is ta n t  s t ra in ,  and bo th  on the  8 th  
day in  those in fe c te d  w ith  the  pa ren t s t ra in .  In  passage 34 one o f  the  
m ice d id  n o t become in fe c te d ; the  second showed p a ra s ite s  in  the  
b lood a f te r  an e x c e p tio n a lly  lo n g  in c u b a tio n  p e r io d  and tre a tm e n t then 
produced a d e f in i t e  response. No fu r th e r  passages were made, as a 
re lapse  s t ra in  most p robab ly  had been developed.
In  v iew  o f  th e  f a i lu r e  described above, i t  was decided to  con tinue  
th e  trea tm en t o f  th e  e xcep tiona l in fe c t io n  in  mouse 7&Lk9 which appeared 
re s is ta n t  to  the  drug a f te r  the  ^Lst trea tm en t (p . 20). Three fu r th e r  
trea tm en ts  w ith  l / L 5*000 g. were given a t  in te r v a ls  o f  a few days, bu t 
again w ith o u t th e ra p e u tic  e f fe c t .  Fresh anim als were in fe c te d  w ith  
th e  p a ra s ite s  from th is  mouse and the  s t ra in  was m ain ta ined in  fu r th e r  
passages, each o f  which was tre a te d  (see Table XV f o r  d e ta i ls ) .  Two 
o f  the  fre s h  m ice, 836D and 837®, in fe c te d  from 76IA  a f te r  the  33r(  ^
and 34 th  trea tm ents re s p e c tiv e ly  were each tre a te d  w ith  severa l doses o f
3-/1*5*000 8* N°* 897 w ith  l i t t l e  o r  no e f fe c t .  In  a l l ,  11 m ice were
in o c u la te d  in  successive passages, b u t one fa i le d  to  become in fe c te d .
Th is  /
-  3 7 -
T h is  somewhat in t r a c ta b le  s t ra in  i s ,  in  gene ra l, more read ily - 
in f lu e n c e d  by the  drug in  a fre s h  h os t than in  the  o r ig in a l  mouse, e .g . 
a fre s h  mouse 85LD was in fe c te d  from 85IC 4 days a f te r  i t s  5th  
tre a tm e n t. A s l ig h t  th e ra p e u tic  e f fe c t  was observed in  t h is  fre s h  
mouse to  trea tm en t w ith  l / 3>000 g. a t  the  acme stage, w h ile  in  mouse 
85IC  th e  4 th , 5 ^  811 cl 6th  trea tm ents  w ith  1 /3 ,000  g. d id  n o t in f lu e n c e  
th e  in fe c t io n .  T h is  obse rva tion  i s ,  o f  course, p a ra l le le d  by the  
r e s u lts  o f  trea tm en t o f  a fre s h  in fe c t io n  from ch ro n ic  (re la p se ) 
p a ra s ite s , as compared w ith  the  trea tm en t o f  the  in fe c t io n  in  the  
o r ig in a l  mouse, th e  fo rm er be ing more re a d ily  cured than the  l a t t e r  (see 
Tab le  V I I ) .  Table XV shows th a t  none o f  the  6 m ice re p e a te d ly  
tre a te d  w ith  the  r e la t iv e ly  la rg e  dose o f  1/ 3,000 g . , o r  th e  2 re p e a te d ly  
tre a te d  w ith  l/L 5 ,0 0 0  g. was cured. A c tu a lly ,  w ith  the  excep tion  
o f  1 animal (852D), l i t t l e  o r  no response re s u lte d  from  the  m a jo r ity  
o f  trea tm en ts , which were given a t  in te r v a ls  o f  app rox im a te ly  7 days.
The v a r ia t io n  in  in d iv id u a l anim als i s  demonstrated by the  re tre a tm e n ts  
o f  m ice Nos. 852C and 852D in fe c te d  w ith  th e  seme inocu lum . In  th e  
fo rm er a l l  5 trea tm en ts  had no e f fe c t ;  in  the l a t t e r  th e re  was a s l ig h t  
response to  th e  f i r s t  4 trea tm ents  and th e  5 th  to  8 th  trea tm en ts  produced 
a d e f in i t e  th e ra p e u tic  e f fe c t ,  bu t th e  9th  and 10th  trea tm en ts  d id  n o t 
reduce th e  number o f  p a ra s ite s  p resen t in  the  b lood.
From e a r ly  passages o f  t h is  s t ra in ,  836D, 852A and 852c, i t  m igh t 
be concluded th a t  d ru g - fa s t p a ra s ite s  had been produced. However, 
th e ra p e u tic  responses were observed in  subsequent passages. In  the  
s e r ie s  o f  passages from jSLk, which v/as r e s is ta n t  to  tre a tm e n t w ith  
No. 897, ending in  863B which fa i le d  to  become in fe c te d ,  the  p a ra s ite s
/
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p a ra s ite s  were passed through 7 mice whose trea tm en ts  t o ta l le d  39 w ith  
1/15,000 g. and 26 w ith  1/ 3,000 g . , and y e t t ru e  d ru g -re s is ta n c e  was 
n o t produced; t h is  confirm s the  d i f f i c u l t y  o f  deve lop ing  an 897-"f’as t  
s t ra in  o f  T. congolense. The se r ie s  o f  passages i s  in d ic a te d  by the  
arrows in  Table XV.
An unsuccess fu l a ttem pt was made to  produce re s is ta n t  p a ra s ite s  
by s u b je c tin g  th e  trypanosomes o f  S tra in  I I  to  the  drug in  s a lin e  
s o lu t io n  f o r  15 m inutes and then in fe c t in g  anim als w ith  the  tre a te d  
trypanosomes. Th is  was c a rr ie d  o u t by adding 0 .5  c .c . o f  the  normal 
inoculum  to  an equal volume o f  1/ 250,000 d i lu t io n  o f  the  drug in  
normal s a lin e , another 0*5  c. c. o f  the  suspension o f  trypanosomes to  
1/400,000 g. o f  the  drug and a 3r d to  0 .5  c. c. o f  s a lin e  a lone . Thus 
the  p a ra s ite s  were a c tu a lly  in  con tact w ith  1/ 500,000 and 1/300,000 
d i lu t io n s  o f  th e  drug re s p e c t iv e ly .  A f te r  15 m inutes m o ti le  trypanosomes 
were observed in  each s o lu t io n . Mice which were in fe c te d  w ith  th e  
tre a te d  trypanosomes had lo n g e r in c u b a tio n  p e r io d s  (10 days) than the  
u n tre a te d  c o n tro l.  When the  in fe c t io n  in  the  mouse which rece ive d  
th e  trypanosomes tre a te d  w ith  the  weaker s o lu t io n  o f  th e  drug was a t  
th e  acme stage, in o c u la  were prepared from i t s  b lood. These were 
tre a te d  w ith  the  same doses o f  the drug as above. In  t h is ,  the  2nd, 
passage through m ice one anim al f a i le d  to  become in fe c te d  and in  the  
o th e r  the  in fe c t io n  had an in c u b a tio n  p e r io d  o f  26 days, w h ile  th a t  o f  
th e  u n tre a te d  c o n tro l was 6 days. H ir th e r  passages were n o t made, as 
a re lapse  s t ra in  had p roba b ly  developed.
Summary /
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Summary, These experim ents show th a t  w ith  T. congolense d rug - 
re s is ta n c e , which i s  fre q u e n t ly  assumed to  be th e  cause o f  fa i lu r e s  
to  cure in  the  f ie l d  (see sec tion  V I I ) ,  i s  n o t so e a s i ly  developed in  
th e  la b o ra to ry  by means o f  No, 897 as in  the  case o f  many drugs w ith  
T, b ru c e i. In  t h is  connection i t  must be remembered, however, th a t  
i t  i s  d i f f i c u l t  to  o b ta in  d ru g - re s is ta n t s tra in s  in  the  usua l way w ith  
B aye r-205 (su ram in ). There are a lso  in d ic a t io n s  th a t  w ith  T. congole nse 
in  m ice lo s s  o f  v iru le n c e  o f  th e  trypanosomes re s u lts  from a ttem pts to  
develop re s is ta n c e  by the  usua l methods.
In  1936 du T o it  re p o rte d  2 a ttem pts to  develop re s is ta n c e  to  
antimosan in  gu inea -p igs  in fe c te d  w ith  T. congolense; f i r s t l y  by 
t r e a t in g  w ith  n o n - s te r i l is in g  doses o f  the  drug and in fe c t in g  a. 
f re s h  hos t w ith  th e  p a ra s ite s  o f  the  re la p se ; and secondly by 
tre a tm e n t o f  successive re lapses in  the  o r ig in a l anim al and o n ly  
in fe c t in g  a fre s h  host when in  danger o f  lo s in g  an an im al. No 
in d ic a t io n s  o f  re s is ta n c e  were observed from e ith e r  method, the  fo rm er 
be ing  c a rr ie d  ove r 32 genera tions and th e  l a t t e r  f o r  54 trea tm en ts  
in  10 anim als.
SECTION V I.
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IMMUNITY RESPONSES AFTER CURE.
IMMUNITY RESPONSES AFTER CURE.
In  gene ra l, trypanosomes are an tigens which s t im u la te  the  p ro d u c tio n  
o f  a n tib o d ie s  in  the  serum o f  the  h o s t. But vd th o u t the  co -o p e ra tio n  o f  
a chem otherapeutic agent the  n a tu ra l defences o f  most anim als are 
in ca p a b le  o f  d ispos ing  e f fe c t iv e ly  o f  the  pa thogen ic  species. However, 
spontaneous recovery from T. congolense in fe c t io n  occurs in  sheep and 
goats (Laveran e t  a l . ,  1902; Laveran, 1911) and young ca lves (van Saceghem, 
1938) > c o n fe r r in g  on them acqu ired  im m unity to  n a tu ra l in fe c t io n  and, in  
th e  case o f  the  ca lves, to  experim enta l re in o c u la t io n .
The ques tion  o f  the  im m unity phenomena fo llo w in g  cure o f  T. congolense 
in fe c t io n s  in  mice w ith  drug No. 897 has been tho rough ly  in ve s tig a .te d .
There are  no pub lished  data  on th is  su b je c t, s ince  h ith e r to  a c u ra t iv e  
agent was n o t a v a ila b le .
R esu lts  w ith  o th e r species o f  trypanosomes have shown th a t  d i f f e r e n t  
s t ra in s  may va ry  in  t h e i r  im m unising power. W ith  some complete re s is ta n c e  
to  re in o c u la t io n  w ith  the  homologous s t ra in  may be produced, w h ile  w ith  
o th e r  s t ra in s  th e re  i s  m ere ly p ro lo n g a tio n  o f  the  in c u b a tio n  p e r io d . 
F u rth e r, such im m unity i s  most pronounced when the  re in o c u la t io n  i s  made 
w ith  the  same s tra in ,  whereas th e re  may be l i t t l e  o r  no im m unity toward 
o th e r  s tra in s .  In  t h is  connection a lso , i t  must be borne in  mind th a t  
when a re lap se  occurs th e  s t ra in  as a r u le  undergoes a change in  i t s
im m unologica l cha rac te rs ; thus  a m u l t ip l i c i t y  o f  s e ro lo g ic a l races may 
develop in  repeated re lapses . T h is  work i s  summarised by Browning, (193L) 
and C u lbertson, (1941). The o n ly  c e r ta in  means fo r  p re s e rv in g  the  
im m unological cha racte rs  o f  a s t ra in  o f  trypanosomes i s  to  oass i t  
con tin uous ly  a t  the  h e ig h t o f  in fe c t io n  (acme) by in o c u la t in g  fre s h  /
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f re s h  anim als o f  the  same h ig h ly  su s c e p tib le  species, in  most cases 
m ice o r  r a ts .  In  an animal such as the  r a b b it  in  which u n tre a te d  
tiypanosome in fe c t io n s ,  e .g . w ith  T. brucei .  u s u a lly  pursue a re la p s in g  
course, a succession o f  s e ro lo g ic a l s t ra in s  tends to  develop. I t  i s  
o f  in te r e s t ,  however, th a t  th e  " s o l id 11 im m unity to  re in fe c t io n  which i s  
acqu ired  a f te r  cure o f  such a re la p s in g  in fe c t io n ,  w h ile  p ro te c t in g  
a ga ins t th e  same s t ra in  which has been passed con tin uous ly  th rough mice 
a t acme, does n o t p ro te c t  a g a in s t another s t ra in  which has been passed 
s im i la r ly  (Browning, Cosgrave and L e ck ie , 1939)*
The p resen t work has been c a rr ie d  o u t in  the  l i g h t  o f  th e  
knowledge summarised above and c e r ta in  nove l obse rva tions  have been 
made.
Methods o f  Dem onstra ting  Im m unity.
The method used to  demonstrate a c t iv e  im m unity i s  th a t  o f  E h r l ic h  
and Shiga, (1904); the  in fe c te d  mouse a f te r  an in te r v a l o f  a week o r  
lo n g e r fo llo w in g  trea tm en t w ith  a c u ra tiv e  dose o f  the  drug, was 
re in o c u la te d  w ith  trypanosomes. The in te r v a l  must, o f  course, be 
s u f f ic ie n t  f o r  a l l  the  drug to  be excre ted . The H ood was then examined 
f o r  trypanosomes as in  a th e ra p e u tic  experim ent. I f  no p a ra s ite s  
appeared w ith in  a month, re in fe c t io n  was concluded n o t to  have occurred . 
Two apparent exceptions are discussed la t e r .
Treatm ent a f te r  re in fe c t io n .  Each cured animal in  which 
re in o c u la t io n  was successfu l in  p roducing  in fe c t io n ,  was tre a te d  w ith  
1 /3 ,000  g. No. 897 im m ed ia te ly  the  p a ra s ite s  became abundant in  the  b lood. 
Before  a fu r th e r  re in o c u la tio n  was c a r r ie d  o u t, a t  le a s t  one month was 
a llow ed to  e lapse, d u rin g  which tim e the  b lood  was examined every 2nd
/
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2nd day in  o rd e r to  e s ta b lis h  cure.
O ther te s ts  co n firm in g  th a t  s t e r i l i s a t io n  had been e ffe c te d . The 
p o s s ib i l i t y  had to  be considered th a t  in  s p ite  o f  fre q u e n t n e g a tive  b lood 
exam inations, the  p a ra s ite s  were p e rs is t in g  in  ve ry  scanty numbers 
e ith e r  owing to  the  o r ig in a l  in fe c t io n  (o r  a r e in fe c t io n )  n o t be ing  
cured o r  to  p e rs is te n c e  o f  the trypanosomes in tro d u ce d  a t the  
re in o c u la t io n .  To confirm  th a t  s t e r i l i s a t io n  had occurred  2 fu r th e r  
methods were used (a) the  in o c u la t io n  o f  an animal w ith  th e  whole b lood 
o f  the  mouse which i s  presumed to  be fre e  from trypanosomes and (b) 
obse rva tion  o f  the  s ize  o f  the  spleens o f  the  experim enta l an im als.
(a) 12 m ice presumably f re e  from trypanosomes accord ing  to  the  
re s u lts  o f  b lood exam inations, were se lec ted  a t random; these had m ostly  
been repea ted ly  re in o c u la te d . They were ch loro fo iroed and one fre s h  
mouse was in je c te d  subcutaneously w ith  the to ta l  volume o f  b lood ob ta ined  
from each h ea rt (§  to  f  c. c . ) .  T h e ir  b lood was examined every 2nd
day f o r  one month, and in  the  case o f  10, the  exam inations were 
continued a t  lo n g e r in te r v a ls  fo r  a p e r io d  up to  4 months. None o f  
these anim als became in fe c te d . Two were re in o c u la te d  w ith  the  normal 
inoculum  o f  acme p a ra s ite s  a t the  end o f  one month; in  each the  
organisms appeared as in  the  u n tre a te d  c o n tro l,  shoving th a t  these 
m ice were su sce p tib le  to  in fe c t io n  and so had n o t acqu ired  im m unity 
owing to  a p rev ious  la te n t  in fe c t io n  w ith  trypanosom e-conta in ing  b lood .
The animal in o c u la t io n  te s t  i s  extrem ely s e n s it iv e , a lthough  e x c e p tio n a lly  
fa i lu r e s  may re s u lt  owing to  the v iru le n c e  o f  the  p a ra s ite s  being h ig h ly  
a tte nua ted  (Browning and Gul bran sen, 1935)*
(b) The spleens o f  animals which have been in fe c te d  w ith
T. congolense fo r  weeks o r  months always show cons ide rab le  enlargement
/
enlargem ent (Browning, CappeLl and Gul bran sen, 1934). A cco rd in g ly , 
th e  spleens o f  14 supposedly cured mice were examined, in  most cases 
a f te r  a t  le a s t  one successfu l re in o c u la tio n  which had been tre a te d ;
12 were norm al in  s ize , w h ile  the  rem ain ing 2 were o n ly  s l ig h t ly  
en larged.
From the  above obse rva tions  i t  may be deduced th a t  in  the  
c ircum stances the  m ic roscop ic  exam ination o f  the  blood was adequate 
f o r  th e  purpose o f  d e te c tin g  trypanosomes and th a t the  q u a n tity  o f  
drug adm in is te red  e ffe c te d  cure o f  the  re in fe c t io n s .
A p p lic a t io n  o f  the  Rieckenberg adhesion phenomenon. A ttem pts to  
app ly  th e  adhesion phenomenon o f  R ieckenberg, (1917) w ith  a v iew  to  
d e te c tin g  im m unological d iffe re n c e s  o r  id e n t i t ie s  among the  v a r io u s  
s t ra in s  proved a f a i lu r e .  The method o f  the  te s t  i s  to  m ix  on a s lid e  
a drop each o f  (a) b lood from a cured mouse, co n ta in in g  the  an tibody ,
(b) c i t r a te  b ro th  and (c) b lood co n ta in in g  the  trypanosomes, i . e .  the  
a n tig e n . A p o s it iv e  re a c t io n , shown by co a tin g  o f  the  trypanosomes 
w ith  b lood  p la te le ts ,  proves th a t  the  an tigen  and an tib ody  are 
homologous. A number o f  workers have confirm ed th e  va lue  o f  t h is  
re a c t io n ; thus Leupold, ( 1 9 ^ )  working w ith  T. b ru ce i c la im ed agreement 
between re in fe c t io n  experim ents and the  adhesion re a c t io n . Duke and 
W allace, (1933), however, were unable to  d is t in g u is h  between passage 
and re lapse  s tra in s  o f  T. rhodesiense by th e i r  red  c e l l  adhesion te s t  
which i s  a m o d if ic a tio n  o f  the  p la te le t  re a c tio n .
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STRAIN I .
Cured Acme In fe c t io ns R e inocu la ted  w ith  Acme P a ra s ite s .
The re s u lts  w ith  S tra in  I  in fe c t io n s  cured a t  acme and re in o c u la te d  
w ith  the  homologous trypanosomes a t the  same stage (acme), u s u a lly  about
1 month a f te r  the  a d m in is tra tio n  o f  the  drug, g ive  conv inc ing  evidence 
o f  a s o l id  im m unity which la s ts  f o r  a t le a s t  13 months — the  lo n g e s t
I
in te r v a l  te s te d . 7 animals — 1539B, I 56OA, I 562A, 1570A, I 58IB , I 588B 
and I 59IA  — were immune to  re in o c u la tio n  from 11 months to  13 months 
a f te r  i n i t i a l  cure . The s ize  o f  th e  inoculum  does n o t a f fe c t  the  r e s u lt ,  
as 4 anim als — I 58IB , I 588B, 1591A and I 633B — m an ifested  complete 
re s is ta n c e  when each was re inoC u la ted  w ith  the  whole h e a rt b lood o f  a 
h e a v ily  in fe c te d  mouse. Two mice — I 529A and I 529B — cured a t the  
acme stage w ith  No. 897* re s is te d  20 re in o c u la tio n s  w ith  acme 
trypanosomes a t  approx im ate ly  f o r t n ig h t ly  in te r v a ls .  4 and 6 weeks 
re s p e c t iv e ly  a f te r  the  20th  re in o c u la t io n , the  m ice were ch loro form ed 
and the  h e a rt b lood t ra n s fe r re d  to fre s h  anim als, which d id  n o t become 
in fe c te d ;  t h is  i s  s tron g  evidence th a t  no l i v in g  trypanosomes had been 
harboured (p . 42). The spleens o f  I 529A and I 529B were normal in  s iz e , 
whereas c h ro n ic a lly  in fe c te d  animals show marked s p le n ic  enlargement ( p .42).
The a c tu a l dose o f  No. 897 adm in is te red , which v a r ie d  from 1 /3 ,000  g. 
to  1/L 0 0 ,000 g. does n o t a f fe c t  the  im m unity response p rov ided  cure i s  
e ffe c te d . The chem ical na tu re  o f  the  c u ra tiv e  drug does n o t appear to  
in f lu e n c e  the  r e s u lt  o f  re in o c u la tio n  w ith  the  homologous organism s. In
2 in s ta n ce s  the  drug was q u in d o lin e  met ho c h lo r id e  ( I . C . I . ) ,  in  2 a 
s u b s t itu te d  q u in d o lin e  m ethoch loride ( I . C . I . )  and in  128 o th e rs  
phenanth rid in ium  d e r iv a tiv e s  re la te d  to  No. 897 (Nos. 621, 893, 894, 1060, 
1504, I 505, 1506, 1507, x 542, 1551* 1565* 1566, I 568, 1569, and /
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and 1573)*  a^ *  32 m ice th e re  was complete re s is ta n c e  to
re in o c u la t io n  w ith  th e  homologous p a ra s ite s .
A t o t a l  o f  55 cured mice re in o c u la te d  w ith  th e  same s t ra in  o f  
acme p a ra s ite s  from 1 week to  13 months a f te r  the  drug had been 
adm in is te red  a l l  re s is te d  re in o c u la t io n .
Cured Acme In fe c t io n s  R e inocu la ted  w ith  Chronic P a ra s ite s .
On the  o th e r hand, the re  i s  p r a c t ic a l ly  no im m unity when anim als 
cured a t acme are re in o c u la te d  w ith  b lood c o n ta in in g  p a ra s ite s  d e rive d  
from  a mouse in  which the  in fe c t io n  has become c h ro n ic , i . e .  w ith  
"c h ro n ic ” p a ra s ite s . Of 55 m ice cured a t the  acme stage, n o t one 
re s is te d  re in o c u la tio n  w ith  a random ch ron ic  inoculum . ALso, 11 
m ice cured a t acme which had re s is te d  re in o d ila t io n  w ith  acme 
p a ra s ite s , were re in o c u la te d  w ith  random ch ron ic  p a ra s ite s ; 10 became 
in fe c te d  and o n ly  one proved re fra c to ry .  In  extens ion  o f  t h is  l i n e  
o f  in v e s t ig a t io n  i t  was found th a t  a mouse in o c u la te d  w ith  the  acme 
s t r a in  and cured a t  acme, a lthough immunised to  trypanosomes d e rive d  
from  any animal a t  acme, p rom ptly  became in fe c te d  when re in o c u la te d  
2 to  4 weeks la t e r  from the  same mouse, whose in fe c t io n  by t h is  tim e  
had become ch ron ic  —  th is  was noted w ith  6 anim als (1415B, 1425B, 
1426B, 1432B, 1503A and 1544A).
Cured Chronic In fe c t io n s  R e inocu la ted  w ith  Acme P a ra s ite s .
When the mice had been in fe c te d  o r ig in a l ly  w ith  a ch ron ic  s t ra in  
and cured, they then re s is te d  re in o c u la tio n  w ith  acme p a ra s ite s  in  the  
same way as those cured o f  acme in fe c t io n .  Out o f  31 anim als th e re  
was o n ly  one excep tion (mouse 1495A, d iscussed la t e r ) .  I t  i s  
no tew orthy  th a t the  im m unity to  acme p a ra s ite s  should be so pronounced 
a f te r  the  cure o f  a ch ron ic  in fe c t io n ;  2 m ice (1552A and 1552B)
/
1552B) o r ig in a l ly  in fe c te d  w ith  ch ron ic  p a ra s ite s  and then cured w ith  
No. 897>each re s is te d  13 re in o c u la tio n s  w ith  acme p a ra s ite s  a t 
app rox im a te ly  f o r t n ig h t ly  in te r v a ls .  4 and 6 weeks re s p e c t iv e ly  a f te r  
th e  13th  re in o c u la t io n  the  anim als were ch loro form ed and the  whole 
h e a rt b lood in je c te d  in to  fre s h  m ice, which d id  n o t become in fe c te d . 
The spleen o f  1552B was s l ig h t ly  en larged, w h ile  th a t  o f  the  o th e r 
was norm al. A lso , as in  the  case o f  cured acme in fe c t io n s ,  the  
re s is ta n c e  to  acme p a ra s ite s  fo llo w in g  cure o f  a ch ron ic  in fe c t io n  
appears to  p e r s is t  f o r  a lo n g  tim e; thus 2 m ice (1600C and I 639A) 
re s is te d  re in fe c t io n  w ith  acme p a ra s ite s  12§- months a f te r  the  
a d m in is tra tio n  o f  the  drug.
Cured Chronic In fe c t io n s  R einocu la ted w ith  Chronic P a ra s ite s .
When th e  o r ig in a l in fe c t io n  and the  in fe c t iv e  b lood used f o r  
re in o c u la t io n  were both  de rive d  from c h ro n ic a lly  in fe c te d  m ice, th e re  
was ve ry  l i t t l e  evidence o f  im m unity to  th e  re in o c u la t io n ; o n ly  1 
o u t o f  15 m ice o f  t h is  c la ss  re s is te d  re in o c u la t io n  w ith  ch ron ic  
trypanosomes.
Thus i t  appears (Tab le  XVI) th a t  fo llo w in g  the  cure o f  e ith e r
acme o r  ch ron ic  S tra in  I  in fe c t io n s ,  the  anim als are a lm ost w ith o u t
excep tion  re s is ta n t  to  re in o c u la tio n  w ith  acme trypanosomes, bu t
u s u a lly  become in fe c te d  a f te r  re in o c u la tio n  w ith  ch ron ic  p a ra s ite s .
S im ila r  responses are noted to  the  2nd and subsequent re in o c u la t io n s .
Successfu l re in o c u la tio n s  w ith  ch ron ic  tiypanosomes were, o f  course,
tre a te d  in  the  manner described ( p .41 ); b u t o c c a s io n a lly  t h is  trea tm en t
f a i le d  to  e f fe c t  cure. In  a l l ,  the  re s u lts  o f  229 re in o c u la t io n s  w ith
acme p a ra s ite s  were observed on 118 cured m ice, o f  which o n ly  1 
produced in fe c t io n  (a  p o s s ib le  exp lana tion  in  t h is  case i s  g iven /
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given la t e r ) .  Whereas 210 o u t o f  a t o ta l  o f  231 re in o c u la t io n s  w ith  
ch ro n ic  p a ra s ite s  te s te d  on 103 cured m ice, were successfu l in  
p roduc ing  in fe c t io n .  By way o f  i l l u s t r a t i o n  re p re s e n ta tiv e  d e ta i ls  
o f  th e  re in o c u la tio n s  o f  4 m ice are g iven in  Table X V II.
Is o la te d  Ins tances o f  Imm unity to  R e in o cu la tio n  
w ith  Chro n ic  Trypanosomes.
O f the  103 m ice (mentioned in  the  preced ing  paragraph) which 
rece ived  random re in o c u la tio n s  w ith  ch ron ic  trypanosomes, 4 proved 
genu ine ly  immune on one occasion and another on 2 occasions ( th e  
re s is ta n c e  o f  the  o th e r re fra c to ry  animals m igh t be e x p lic a b le  on 
o th e r  grounds (see be low )). These immune mice were re in o c u la te d  a t 
d i f f e r e n t  tim es. 2 (1480B and I 50OA) had been in fe c te d  
o r ig in a l ly  w ith  ch ron ic  p a ra s ite s  and a f te r  cure had been re in fe c te d  
once and tw ice  re s p e c t iv e ly  w ith  random ch ron ic  trypanosomes 
b e fo re  p ro v in g  immune to  a fu r th e r  ch ron ic  re in o c u la t io n .  The 
o th e rs  ( I 516A sad 15^5®) were in fe c te d  o r ig in a l ly  w ith  acme 
trypanosomes and a f te r  re in fe c t io n  w ith  ch ron ic  p a ra s ite s  on 
1 and 2 occasions re s p e c tiv e ly  com ple te ly  re s is te d  the  n e x t ch ron ic  
re inocu lum . 2 o f  those 4 d ied  in  t e r  c u r re n tly ,  and the  o th e r 2 
were subsequently re in fe c te d  w ith  ch ron ic  p a ra s ite s . The f i f t h  
mouse (1534A) a f te r  cure o f  the  o r ig in a l in fe c t io n  w ith  ch ron ic  
p a ra s ite s  and 2 re in fe c t io n s  w ith  ch ron ic  trypanosomes, was immune 
to  a 3rd  and 4 th  random re in o c u la tio n  w ith  ch ron ic  trypano somes, 
b u t became re in fe c te d  by the
I t  i s  p o s s ib le  th a t  in  a l l  these cured mice the  a n tib o d ie s  
corresponded w ith  th e  recep to rs  o f  the  ch ron ic  trypanosomes o f  the  
inoculum  to  which they proved re s is ta n t .  On the  o th e r  hand, some 
o f  these mice may have had an increased  n a tu ra l re s is ta n c e  to  the  
c h ro n ic  p a ra s ite s , which would account f o r  t h e i r  w ith s ta n d in g  th e  
r  e ino cu l a t io n .
Increased S u s c e p t ib i l i ty  to  R e in o cu la tio n  w ith  
Chronic Trypanosomes Shown by Cured M ice.
In  experiments on the  re in o c u la tio n  o f  cured anim als w ith  in o c u la  
d e rive d  from c h ro n ic a lly  in fe c te d  m ice, an in te r e s t in g  o b se rva tion  on th e  
d u ra tio n  o f  the  in c u b a tio n  p e r io d  has been made.
i
The in c u b a tio n  p e rio d s  f o r  in fe c t io n s  o f  normal m ice w ith  an
inoculum  o f  ch ron ic  p a ra s ite s  are lo n g e r than the correspond ing p e r io d s
w ith  acme in fe c t io n s  (see p . 6) — u s u a lly  9 to  13 days in  the  fo rm er 
case. I f ,  however, the  same chron ic  inoculum  i s  used to  in fe c t  fre s h  /
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f re s h  m ice and a lso  to  re in o c u la te  cured mice — ir r e s p e c t iv e  o f  whether 
th e  o r ig in a l  in fe c t io n  was acme o r  ch ron ic  — the  in c u b a tio n  p e r io d s  o f  
th e  re in fe c t io n s ,  co n tra ry  to  what would be expected, are u s u a lly  a 
few-days s h o rte r  than those o f  the  un tre a te d  anim als (see in fe c t io n s  
from  mice 1524A, 1549B and I 6I 9A (s e r ie s  1 , 2 and 3 Table X V I I I ) ) .  Thus 
in  the  case o f  80 cured mice which rece ived I 50 re in o c u la tio n s  w ith  
ch ro n ic  p a ra s ite s , the  in cu b a tio n  p e rio ds  were s h o rte r  on 97 occasions 
than the  in c u b a tio n  pe riods  o f  th e  corresponding c o n tro l an im als, w h ile  
on 36 occasions they  were lo n g e r — i t  should be added th a t th e  l a t t e r  
f ig u r e  in c lu d e s  12 re in o c u la tio n s  which fa i le d  to  produce in fe c t io n .
The in c u b a tio n  p e rio d s  o f  the  rem ain ing 17 r e in fe c t io n s  were o f  th e  same 
d u ra tio n  as those o f  the c o n tro ls . These re s u lts  are s t a t i s t i c a l l y  
h ig h ly  s ig n if ic a n t .
Th is r e s u lt  was unexpected, s ince some degree o f  im m unity to  such 
a re in o c u la tio n  fo llo w in g  the  cure o f  a ch ron ic  in fe c t io n ,  m an ifes ted  
p o s s ib ly  by a few days* p ro t ra c t io n  o f  the  in c u b a tio n  p e r io d , was 
a n t ic ip a te d , s im ila r  to  th a t  observed w ith  c e r ta in  s tra in s  o f  
T. b ru ce i (Browning, 1927)*
Result s  o f  re in o c u la tio n  o f  (a) m ice in fe c te d  w ith  the  acme s t ra in  and 
cured a f te r  a re lap se  f o l low i ng in s u f f ic ie n t  t reatm en t a t acme;
(b ) anim als in o c u la te d  from such a re lapse  then cured; and (c) m ice in  
which the  in fe c t io n  had become chroni c  be fo re  c u ra t iv e  trea tm en t.
The study o f  the  im m unological p ro p e rt ie s  o f  S tra in  I  in fe c t io n s  was 
completed by the fo llo w in g  3 s e r ie s , (a) The re la p s € s in  4 m ice ( I 525B, 
I 527A, 1527B and I 528B) fo llo w in g  trea tm en t w ith  1 /75 ,000 g. were cured
w ith  1 /3 ,000  g. No. 897. (b) 4 mice (1577A, 1578A, 1579B and I 58OB) were
in o c u la te d  from anim als which had re lapsed a f te r  trea tm en t w ith
1A 00,000 g .; the  in fe c t io n  which developed was then cured w ith  1/ 3,000 g. ^
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1 /3 ,000  g. No. 897. (c ) 7 m ice ( I 625A, I 625B, I 627B, 1628a, I 637A,
I 638A find I 638B) in  which the  in fe c t io n  had become ch ro n ic , i . e .  3
6 weeks a f te r  th e  acme were cured w ith  a dose o f  1/ 5,000 g. o r . 1 / 10,000 g.
No. 897» A l l  these 15 cured mice behaved on re in o c u la tio n  w ith  acme
o r  random ch ro n ic  p a ra s ite s  in  the  same way as those cured o f  in fe c t io n s
w ith  acme o r  ch ron ic  p a ra s ite s , i . e .  they  re s is te d  the  fo rm er and became
in fe c te d  w ith  the  la t t e r .
Anoma lous Responses to  R e inocu la tion  shown by M ice Cured 
o f  an In fe c t io n  w ith  Chronic P a ra s ite s .
O f the  176 m ice re in o c u la te d  w ith  S tra in  I  trypanosomes derived  
from v a rio u s  stages, 2 anim als (1495A end 1532A) 8-**e e xce p tio n a l 
(Tab le  X IX ). In  a l l  the  o th e rs  the  re a c tio n  to  the  re in o c u la t io n  
was a b s o lu te ly  d e f in ite ,  e i th e r  im m unity o r  prompt re in fe c t io n .
Mouse 1495A in fe c te d  o r ig in a l ly  w ith  ch ron ic  p a ra s ite s  and 
tre a te d  w ith  l/3 ,0 0 0  g. No. 897, ^ as re in o c u la te d  63 days la t e r  
w ith  acme tiypanosomes; 22 days a fte rw ards  scanty p a ra s ite s  were 
observed in  the  b lood f o r  the  f i r s t  tim e ; they increased  to  ++ 
on the  23rd  day and d im in ished  s l ig h t ly  on the  24th day, bu t 
d isappeared on the  25th  day. On the 34t h  day scanty p a ra s ite s  
were again p resen t in  the  b lood; they now increased  no rm a lly  to  
the  abundant stage, a t  which the  animal was tre a te d  w ith  
1 /3 ,000  g. No. 897• Three fu r th e r  re in o c u la tio n s  w ith  acme
p a ra s ite s  were com plete ly re s is te d . Here, the  p o s s ib i l i t y  must 
be considered th a t the o r ig in a l in fe c t io n  was n o t cured, b u t th a t  
an extrem ely la te  re lapse  occurred . On the  o th e r hand, i t  cannot 
be excluded th a t  the lo n g  in cu b a tio n  p e r io d  fo llo w e d  by the  
spontaneous disappearance o f  the  trypanosomes in d ic a te d  a h igh  
degree o f  immunity to  th e  acme p a ra s ite s , ju s t  sh o rt o f  complete 
re fra c to r in e s s .
Mouse 1532A, o r ig in a l ly  in fe c te d  w ith  ch ron ic  p a ra s ite s , 
rece ive d  a dose o f  1 /3 ,000 g. No, 897; 1? days la t e r  i t  was
re in o c u la te d  w ith  ch ron ic  p a ra s ite s ; and as tiypanosomes appeared 
in  the  b lood  a f te r  9 days, the  same dose o f  the  drug was in je c te d .
31 days la t e r  a 2nd re in o c u la tio n  w ith  ch ron ic  p a ra s ite s  was 
c a rr ie d  o u t; as no trypanosomes were de tec ted  in  the  b lood (examined
every 2nd day), an inoculum  o f  acme p a ra s ite s  was in je c te d  32 days 
a f te r  the  p rev ious re in o c u la t io n . Scanty tiypanosomes were 
observed in  the blood 9 days la te r ;  a lthough f lu c tu a t io n  in  numbers 
occurred  ove r the  n e x t 3 weeks, they never became abundant. Here 
i t  seems most probable  th a t the 2nd re in o c u la tio n  w ith  a ch ron ic  
inoculum  had le d  to  in fe c t io n  a f te r  an e x c e p tio n a lly  lo n g  in cu b a t­
io n  p e r io d  (41 days).
R e s is tance /
R esistance o f  Normal and Cured Mice to  an 
Inoculum  of^ Chronic Trypanosomes.
I t  has been seen th a t almost 28 per cent, o f  fre s h  mj ce 
in o c u la te d  w ith  chron ic  p a ra s ite s , f a i l  to  become 
in fe c te d  (p . 1 6 ); thus i t  may be in fe r re d  th a t the 
trypanosomes a t  th a t stage o f  the in fe c t io n  are n o t so 
v i r u le n t  as a t the  acme. N everthe less, i t  appears th a t  
few er cured mice r e s is t  in fe c t io n  w ith  a chron ic  inoculum  
than do f re s h  anim als. Thus o f  23L ch ron ic  re in o c u la tio n s  
te s te d  on cured m ice, o n ly  21 (9 per ce n t.)  were re s is te d .
These r e s u lts  are s t a t i s t i c a l l y  h ig h ly  s ig n if ic a n t .  fU r th e r ,  
o u t o f  55 in o c u la  o f  ch ron ic  trypanosomes used to  re in o c u la te  
groups o f  from 2 to  6 m ice, 4 fa i le d  to  produce in fe c t io n  in  
th e  c o n tro l anim als, w h ile  re in fe c t io n  occurred in  a l l  the  
cured mice o f  these se ts . In  a la rg e  number o f  the  rem ain ing 
se ts  o f  m ice, the in cu b a tio n  periods o f  the re in o c u la te d  mice 
were s h o r te r  by a few days than those in  the corresponding 
c o n tro l anim als ( p .48). I t  i s  no t determ ined whether t h is  
in c rea sed  s u s c e p t ib i l i t y  i s  due to a l le rg y  o r  whether i t  
r e s u lts  from a decrease in  n a tu ra l re s is ta n c e  caused by the  
e f fe c ts  o f  p rev ious in fe c t io n  o r  o f  the drug.
Does In o c u la t ion w ith  Chronic Trypanosomes o f  Low 
V iru le nce which F a ils  to  Cause Obvious In fe c t i on,
Produce Immunity to Subsequent R e inocu la tion  w ith  
C hronic Trypanosomes?
As m entioned, van Saceghem, (1938) claimed th a t  im m unity to  
bo th  n a tu ra l in fe c t io n  and experim ental re in fe c t io n  fo llo w s  
the  spontaneous cure o f  a benign in fe c t io n  in  young ca lves.
I t  appears from the p resen t work th a t mice cured e ith e r  a t  
acme o r  when c h ro n ic a lly  in fe c te d  may o c c a s io n a lly  acqu ire  
im m unity  to  re in fe c t io n  w ith  a chron ic s t ra in  as a r e s u lt  o f  
a p reced ing  in o c u la tio n  w ith  chron ic trypanosomes o f  low  
v iru le n c e  which f a i l s  to  se t up obvious in fe c t io n .  The evidence 
i s  as fo llo w s . In o c u la  de rived  from 4 chron ic  animals appeared 
to  be o f  ve ry  low  v iru le n c e , since none o f  the  4 cured mice 
in o c u la te d  from 2 o f  then (1514A and 1524D) became in fe c te d ,  w h ile  
6 o u t o f  9 cured mice fa i le d  to  become in fe c te d  w ith  in o c u la  
from  th e  o th e r 2 (1602C and 1&2D) — se rie s  4 ,5 ,8  and 9, Table 
X V II I .  These 10 re fra c to ry  mice rece ived  a fu r th e r  ch ron ic
inocu lum , which 4 (1408A, 15L5B> spd 15^7A) re s is te d  in
so f a r  th a t  number I 567A showed a considerab le  p ro tra c t io n  o f  the  
in c u b a tio n  p e r io d , w h ile  number 1498A m anifested p a ra s ite s  in  
th e  b lood t ra n s ie n t ly  10 days a f te r  the re in o c u la tio n  and the 
fa s tig iu m  was n o t a tta in e d  u n t i l  13 days la te r ;  bo th  were cured 
by th e  drug. The o th e r 2 mice never showed trypanosomes in  t h e i r  
b lood . However, on the  fo llo w in g  re in o c u la tio n  w ith  random ch ron ic  
trypanosomes 3 o f  the  4 became re in fe c te d  prom ptly  and the  4 th  a f te r  
a p ro tra c te d  in c u b a tio n  p e rio d . A cco rd ing ly , any im m unity fo llo w in g  
in o c u la t io n  w ith  ch ron ic  tiypanosomes o f  d im in ished v iru le n c e , was o f
lo w  degree and evanescent.
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Do t he A n tig ens o f  the Trypanosomes A lte r  P ro g re s s iv e ly  in  the  
Course o f  a Chroni c I n f ection?
The fa c t  has already.been noted (p . 45) th a t  a mouse cured a t  acme, 
a lth o u g h  immune to  re in o c u la tio n  w ith  trypanosomes from another animal 
a t  acme, d id  n o t r e s is t  in fe c t io n  from the  l a t t e r  a f te r  i t  had reached 
th e  ch ro n ic  stage. The problem now remained whether the  im m unological 
change in  the  trypanosomes o f  a c h ro n ic a lly  in fe c te d  animal was 
cons tan t o r  p ro g re ss ive . A cco rd ing ly , the  experiments d e ta ile d  in  
Tables XX and XXI were c a rr ie d  ou t. Two groups o f  animals were s tu d ie d : -
(a ) in  which an animal in o cu la te d  o r ig in a l ly  from a chron ic  in fe c t io n  
re c e iv e d  a c u ra t iv e  dose o f  the  drug and 11 to 3^ days la t e r  was 
re in o c u la te d  from the  same mouse. None o f  the  9 mice showed im m unity 
to  the  re in o c u la tio n  — d e ta i ls  are given in  Table XX.
(b ) From the  experiments described above and on p. 45, i t  appeared th a t  
a mouse cured e ith e r  o f  the  acme in fe c t io n  o r  a ch ron ic  in fe c t io n  
would in  a l l  l ik e l ih o o d  prove n o t to  be immune on re in o c u la tio n  w ith  
c h ro n ic  trypanosomes from a random source, since the  im m unological 
ch a ra c te rs  o f  a s t ra in  underwent p rog ress ive  change in  the  course o f
a ch ro n ic  in fe c t io n  in  each animal.' To te s t  t h is  p o in t  fu r th e r ,  m ice
o r ig in a l ly  in fe c te d  w ith  acme trypanosomes and cured, were in  the
course o f  a se rie s  o f  re in o c u la tio n s  re in fe c te d  w ith  random ch ron ic
p a ra s ite s  and again cured, re in fe c t io n  and cure being e ffe c te d  severa l
tim es in  some o f  the  animals. F in a l ly  a f te r  cure o f  a r e in fe c t io n  w ith
ch ro n ic  trypanosomes,each mouse was re in o c u la te d  a f te r  an in te r v a l o f
10 to  17 days — once a f te r  57 days — from the  same ch ron ic  mouse as
on the  im m edia te ly  p reced ing  occasion. The re s u lt  was th a t  in  6 o u t 
o f  8 anim als the re  was no im m unity, whereas in  the  o th e r 2 (1432A and /
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and 1540B) the  repeated in o c u la tio n  d id  n o t le a d  to  in fe c t io n  (see 
Table XXE). I t  m igh t be argued th a t in  c o n tra s t w ith  what i s  found 
a f te r  cure o f  an acme in fe c t io n ,  the im m unity fo llo w in g  cure o f  
in fe c t io n  de rive d  from a chron ic  inoculum was o f  sho rt d u ra tio n , as 
i s  u s u a lly  the  case w ith  T. b ruce i in fe c t io n s  (Browning and Gulbransen, 
1936)® A cco rd in g ly , the  re in o c u la tio n s  in  these experiments were 
c h ie f ly  c a r r ie d  o u t 10 to  20 days a f te r  the  a d m in is tra tio n  o f  the  drug. 
The r e s u lts ,  however, do n o t a f fo rd  evidence th a t th e re  i s  an im m unity 
response which reaches a h e igh t s h o r t ly  a f te r  cure and then ra p id ly  
f a l l s  o f f .
F ix a t io n  o f  the  Imm unological Characters of  a C hron ic 
I n f e c t ion by Passage.
I t  has been seen th a t  when a mouse in fe c te d  w ith  T. congolense 
S tra in  I  su rv ive s  the  acme o f  in fe c t io n  the  trypanosomes undergo 
changes in  t h e i r  im m unological characte rs ; i t  may be sa id  th a t  they 
are  c h ro n ic  s tra in s . F u rth e r, these changes appear to  be p rog ress ive . 
T h is  p ro g re ss ive  a lte ra t io n  can be prevented by f a s t ig ia l  p ropagation 
o f  a c h ro n ic  s t ra in ,  i . e .  by in o c u la t in g  fre s h  mice w ith  the  ch ron ic  
trypanosomes and passing the  in fe c t io n  to  fu r th e r  mice as soon as 
p a ra s ite s  become abundant in  the  blood, — re fe rre d  to  as a f ix e d  
ch ro n ic  s t r a in . In  the  course o f  repeated passages the  im m unological 
ch a ra c te r o f  the  trypanosomes tends to re v e r t to  the  acute acme type; 
b u t t h is  does n o t occur u n t i l  a f te r  a t le a s t  one passage and fre q u e n tly  
re q u ire s  a considerab le  number o f  passages.
A cco rd in g ly , one can o b ta in  fo r  a tim e a s t ra in  w ith  f ix e d  ch ron ic
im m unolog ica l characte rs  apparen tly  id e n t ic a l w ith  those in  the  o r ig in a l 
ch ro n ic  mouse. The evidence fo r  th is  i s  as fo llo w s . A se r ie s  o f  /
o f  m ice are in o c u la te d  from a c h ro n ic a lly  in fe c te d  an im al; severa l 
o f  these are  used f o r  p ropagating  the s t ra in  f a s t ig ia l l y ,  and the  
r e s t  are cured by trea tm en t w ith  1 /3 ,000 g. No. 897 a t  the  fa s tig iu m . 
These cured animals now r e s is t  re in o c u la tio n  w ith  the  homologous 
f ix e d  ch ro n ic  s t ra in .  On the o th e r hand, n e ith e r  mice in fe c te d  from 
ano the r ch ron ic  animal and cured (p . 46), n o r cured acne m ice 
m a n ife s t im m unity to  th is  f ix e d  chron ic  s t ra in  (Table X X II) .  F u rth e r 
d e ta i ls  concern ing the  e f fe c ts  o f  continued passages on chron ic  
tiypanosomes are given in  the nex t paragraph.
The Immunologica l Charac te rs o f  Ch ro n i c Trypano somes 
as Af fe c te d  by Continued Passage.
As mentioned above, the  im m unological cha racte rs  have been 
in v e s tig a te d  in  the case o f  severa l s tra in s  o f  ch ron ic  trypanosomes 
w hich have been f a s t i  g ia l ly  propagated — re fe rre d  to  h e re a fte r  as 
passaged ch ron ic  trypanosomes. ( i t  has been shown a lready th a t  the 
im m unolog ica l cha racte rs  o f  such a s tra in  remain f ix e d  f o r  one passage 
a t le a s t ) .  These passaged ch ron ic  trypanosomes were used in  successive 
passages to  re in o c u la te  mice o f  the o r ig in a l acme s t ra in  which had 
been cured a t  acme. I f  in fe c t io n  occurred i t  could be in fe r re d  th a t  
th e  ch ron ic  characte rs  had p e rs is te d ; i f ,  on the  o th e r hand, im m unity 
was m an ifested  i t  appeared th a t  the trypanosomes had re ve rte d  to  the  
cha rac te rs  o f  the  acme s tra in .  Nine separate ch ron ic  s tra in s  were 
passaged and te s te d  in  t h is  way (see Table X X T II); i t  has been found 
th a t  the  acme characte rs  may be regained a f te r  a v a r ia b le  number o f  
passages, e .g . 3 to  9, w h ile  in  some s tra in s  th e  chron ic  cha racte rs
p e rs is te d  u n t i l  the  9 th  to  the  12 th  passage, the  la te s t  te s te d . Where 
the  acme characte rs  had been regained, t h is  was always confirm ed by 
re p e a tin g  the  te s t  f o r  immunity w ith  la t e r  passages.
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On account o f  the  tendency f o r  mice no t to  become in fe c te d  w ith  
c h ro n ic  p a ra s ite s , attem pts to  e s ta b lis h  passages o f  seve ra l o th e r 
c h ro n ic  s t ra in s  fa i le d .
I t  i s  n o t d e a r  from the re s u lts  whether the in te r v a l  (14 to  
37 days) a f te r  the  acme stage before  passages were s ta r te d , i s  
s ig n i f ic a n t  in  regard to  the  number o f  passages re q u ire d  to  re ­
e s ta b lis h  th e  acme characte rs . A c tu a lly , those s tra in s  de rived  from 
m ice 14 to  24 days a f te r  the acme stage, preserved th e i r  ch ron ic  
c h a ra c te rs  ove r a g re a te r number o f  passages than those derived  a f te r  
a s l ig h t ly  lo n g e r in te r v a l ,  bu t t h is  may be fo r tu i to u s .
In  s t ra in s  A and B the chron ic  cha rac te r a lte re d  in  the  course 
o f  n o t more than 3 o r  4 passages. Th is may also have been the  case 
w ith  s t r a in  D, which was te s te d  fo r  the  f i r s t  tim e in  the  6th  passage.
Summary  and C ondusions.
I t  i s  w e ll es tab lished  th a t  a remarkably s o l id  im m unity to 
re in o c u la t io n  w ith  acme trypanosomes devdops in  mice in fe c te d  w ith  
T. congolense S tra in  I  and cured w ith  a chemotherapeutic agent e ith e r  
a t  acme o r  in  the  chron ic  stage. Th is im m unity la s ts  f o r  a t le a s t  
13 months a f te r  cure. (No. 897 has been used c h ie f ly  as the  th e ra p e u tic  
agent; o th e r  drugs have been used w ith  a s im ila r  r e s u lt ,  bu t o n ly  acme 
in fe c t io n s  have been tre a te d  w ith  the la t t e r ) .  This im m unity i s  
genuine and i s  n o t accounted f o r  by p ro p h y la c t ic  a c tio n  o f  the  drug, 
which o n ly  la s ts  fo r  le s s  than 4 days a f te r  the  a d m in is tra tio n  o f  a
la rg e  dose — 1/ 1,000 g.
Under s im ila r  co n d itio n s , p r a c t ic a l ly  no im m unity i s  e v iden t to
re in o c u la t io n  w ith  random s tra in s  o f  ch ron ic  trypanosomes, ir re s p e c t iv e  
o f  the  n a tu re  o f  the o r ig in a l in fe c t io n  o f  th e  host, whether acme o r  /
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o r  ch ro n ic . T h is  ho lds even when re in o c u la tio n  i s  c a r r ie d  o u t a few 
days a f te r  trea tm en t; and even i f  the  mouse i s  re in o c u la te d  from the  
same anim al as 3f te ld e d  the o r ig in a l in fe c t io n .  A f te r  cure o f  repeated 
re in fe c t io n s  w ith  ch ron ic  tiypanosomes fu r th e r  in o c u la t io n s  w ith  the  
acme s t ra in  were a lso  re s is te d , w h ile  s im ila r  re5.noc u la tio n s  vd th  
c h ro n ic  p a ra s ite s  alm ost always caused in fe c t io n .
Exceptions in  the  sense o f  im m unity to  random s tra in s  o f  ch ron ic  
trypanosomes, are ve ry  ra re  in  s p ite  o f  the  la rg e  numbers o f  
re in b c u la t io n s  c a rr ie d  ou t. The fo llo w in g  p o s s ib i l i t ie s  to  account 
f o r  these  exceptions may be considered, (a) The n a tu ra l re s is ta n ce  
o f  m ice to  re in o c u la tio n  w ith  ch ron ic  trypanosomes, which are g e n e ra lly  
reduced in  v iru le n c e . A c tu a lly , animals cured o f  a ch ron ic  in fe c t io n  
are  more su sce p tib le  to re in fe c t io n  w ith  a random ch ron ic  s tra in  than 
are  norm al m ice. (b) Im m unity may be con fe rred  on mice by p rev ious  
in o c u la t io n  w ith  ch ron ic  trypanosomps o f  lov/ v iru le n c e  which fa i le d  
to  produce obvious re in fe c t io n .  Such im m unity, however, has been 
shorn to  be tra n s ie n t,  (c ) O ccas iona lly  i t  may happen th a t  the  
com bination o f  recep to rs  in  the trypanosomes used fo r  the  re in o c u la tio n  
corresponds w ith  those to  which a n tib od ies  have been developed in  the  
cured an im a l. Th is  exp lana tion  i s  supported by the  fa c t  th a t  the  
im m unity  was n o t e f fe c t iv e  aga ins t subsequent in o c u la t io n  w ith  o th e r 
ch ro n ic  tiypanosomes.
The immunological cha rac te r o f  the  in fe c t io n  undergoes p rog ress ive  
change in  each c h ro n ic a lly  in fe c te d  anim al. However, by t ra n s fe r  o f  a 
ch ro n ic  in fe c t io n  to  fre s h  mice and passage th e re a f te r  as soon as the
number o f  p a ra s ite s  in  th e  blood becomes abundant, i . e .  a t  fa s tig iu m , 
th e  im m unological characte rs  o f  a s tra in  may be preserved u n a lte re d  /
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u n a lte re d  f o r  one o r  severa l passages, i . e .  a f ix e d  ch ron ic  s tra in  may 
be e s ta b lis h e d . But repeated passages a t fa s tig iu n i tend e v e n tu a lly  
to  produce trypanosomes w ith  the im m unological cha rac te r o f  the  acme 
s t r a in .  The number o f  passages re q u ire d  be fore  re ve rs io n  to  the 
acme s t ra in  i s  very v a r ia b le , e .g. w ith in  3 to  over 12.
E h r l ic h f s re c e p to r theo ry  and th e above data . The f in d in g s  may be 
s a t is f a c t o r i ly  exp la ined on the basis o f  the  recep to r theo ry  o f  E h r lic h . 
I t  i s  c le a r  th a t the acme s tra in  o f  T. congolense I  possesses constant 
im m unolog ica l characte rs  — o r  a n tig e n ic  recep to rs  (A recep to rs ) — 
s ince  a mouse cured a t acme has a la s t in g  s o lid  im m unity to  trypanosomes 
d e riv e d  from any o th e r mouse in fe c te d  w ith  the  same acme s t ra in .  When, 
as i s  fre q u e n t, an u n tre a te d  in fe c te d  animal su rv ives the  acme stage 
o r  when an in s u f f ic ie n t ly  tre a te d  acme in fe c t io n  re lapses , the 
im m unolog ica l characters o f  the trypanosomes a l te r .  Th is  i s  shown by 
th e  f a c t  th a t  on in o c u la t io n  in to  mice cured o f  an acme in fe c t io n  they 
re a d i ly  produce in fe c t io n .  So fa r  the  phenomena resemble those met 
w ith  in  re lapse  s tra in s  o f  T» b ru ce i; bu t here the  resemblance ceases, 
because a mouse cured o f  a ch ron ic  in fe c t io n  w ith  T. congolense o r  o f  
a re la p se , i s  s t i l l  in s u s c e p tib le  to re in fe c t io n  w ith  the  acme s t ra in .
Chron ic s tra in s  are im m uno log ica lly  heterogeneous, because cure 
o f  a ch ro n ic  in fe c t io n  does n o t as a ru le  con fe r im m unity aga inst 
random re in o c u la tio n  w ith  trypanosomes from o th e r c h ro n ic a lly  in fe c te d  
mjLcej and even when a mouse cured o f  in fe c t io n  de rived  from a ch ron ic  
anim al i s  again re in o c u la te d  from the  same animal in fe c t io n  fo llo w s ,
•whi r>V| shows th a t  the  trypanosomes have a lte re d  im m uno log ica lly  in  the
c h ro n ic a lly  in fe c te d  mouse in  the in te r v a l between the  2 in o c u la . On 
th e  o th e r  hand, the re  are the  fu r th e r  fa c ts  — ' ( 1) the  immunological
/
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im m unolog ice l cha racte rs  o f  a chron ic s t ra in  may be te m p o ra r ily  f ix e d  
by f a s t ig ia l  passage and ( 2) on repeated f a s t ig ia l  passages the re  i s  a 
tendency to  re ve rs io n  to  the acme type e v e n tu a lly .
A c co rd in g ly , when the in fe c t io n  becomes chron ic  a d d it io n a l re cep to rs  
develop in  response to  the ac tion  on the  tiypanosomes exerted  by the 
defence mechanisms o f  the  host, bu t they  do n o t rep lace  the  o r ig in a l 
A ty p e . Thus the  recep to rs  o f  trypanosomes in  a c h ro n ic a lly  in fe c te d  
anim al may be regarded as becoming p ro g re s s iv e ly  A+B, A+B+C, and so on, 
which on cure g ive  r is e  to  an tib od ies  w ith  the characte rs  anti-A+B , 
anti-A+B+C e tc . re s p e c tiv e ly . Thus, a mouse whose im m unity depended 
on an ti-A +B  would r e s is t  re in o c u la tio n  w ith  trypano somes possessing 
re c e p to rs  A o r  A+B (o r  B), bu t n o t w ith  those which conta ined a d d it io n a l 
re c e p to rs , e .g . C as in  A+B+C, e tc . The e f fe c t  o f  continued f a s t ig ia l  
passages i s  to  p reven t development and accum ulation o f  a d d it io n a l 
re c e p to rs  and e ve n tu a lly  to  le ad  to  t h e i r  disappearance.
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STRAIN I I
Cured Acme In fe c t io n s  Reinoculated w ith  Acme P a ras ite s *
In  th e  case o f  the  second s tra in  o f  T. congolense ( I I ) ,  in  c o n tra s t 
to  S tra in  I ,  when m ice cured a t acme were re in o c u la te d  w ith  the  
homologous trypanosomes taken from an in fe c te d  mouse a t acme, s o l id  
im m un ity  was n o t m anifested in  100 p e r cen t. I t  appeared ra th e r  
th a t  th e  chances o f  im m unity and re in fe c t io n  are (equalA a lm ost^(Tab!e 
XXIV — r e s u lt  o f  f i r s t  re in o c u la t io n ) ,  22 mice ou t o f  40 r e s is t in g  
re in o  cu l a t io n .
The amount o f  No. 897 adm in istered to  cure the  i n i t i a l  in fe c t io n  
v a r ie d  between 1 /3 ,000 g. and 1/15,000 g. A n a lys is  o f  the  responses 
to  subsequent re in o  cu l a t io n  s showed th a t  the dose o f  drug does n o t 
a f fe c t  the  r e s u lt .  Only one mouse was re in o cu la te d  which had been 
tre a te d  w ith  a drug o th e r than No. 897? v iz .  No. 71-5A> which was n o t 
immune to  re in o c u la tio n  w ith  the acme s tra in  94 days a f te r  trea tm ent 
w ith  a s u b s titu te d  q u in d o lin e  raethochloride ( I . C . I . ) .
The in te r v a l between the  a d m in is tra tio n  o f  the  drug and the 
re in o  c u l a t io n  d id  n o t a f fe c t  the  r e s u lt ,  as can be seen from the 
fo llo w in g  ta b le , which shows th a t immunity to  a 1s t  re in o c u la tio n  may 
o r  may n o t be p resen t soon a f te r  the  trea tm ent and a lso th a t  e ith e r  
r e d u l t  may fo llo w  re in o c u la tio n  about 8 months a f te r  cure.
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No, o f  In te r v a l in  days between trea tm ent o f  the  o r ig in a l  
Mouse, m ie c t io n  and the  1 s t re in o c u la tio n ,
688B o
R esu lt.
689A 
615A 
603A 
689B 
688a
257
9
208
7
Immune
Not immune
597A 240
591A 274
R esu lts  o f  Repeated R e ino cu la tio ns and Retreatm ents.
A dose o f  1 /3 ,000 g. No. 897 was given im m edia te ly the  p a ra s ite s  
o f  a r e in fe c t io n  became abundant in  the  blood and in  most cases an 
in te r v a l  was allowed o f  a t le a s t  1 month a fte rw ards be fo re  a fu r th e r  
in o c u la t io n ;  p rov ided  the  blood exam inations c a rr ie d  ou t every 2nd 
day d u r in g  th a t  tim e were u n ifo rm ly  n e g a tive , cure was considered to  
have been e ffe c te d . Th is  dose fa i le d  to  cure 9 o u t o f  27 re in fe c te d  
m ice, w h ile  w ith  the o r ig in a l in fe c t io n  a t acme the re  was 1 f a i lu r e  
o u t o f  13 s im i la r ly  tre a te d  (Table IV ) .  These f ig u re s  are 
s t a t i s t i c a l l y  in s ig n if ic a n t .
The 2nd and subsequent re in o c u la tio n s , ir r e s p e c t iv e  o f  whether 
th e  1 s t  re in o c u la tio n  was re s is te d  o r  succeeded in  p roducing  in fe c t io n ,
aga in le d  to  in fe c t io n  in  approxim ate ly 50 p e r cent, o f  the  cases; tx it  
th e re  seemed to  be a tendency to  a h ighe r p ro p o rtio n  o f  immunes as 
the  number o f  re in o c u la tio n s  increased (Table  XXV — m ice 701 A, 73^3, 
760B and 792A). However, mouse 754B was re in fe c te d  by the  6 th
re in o e o la tio n  a f te r  d is p la y in g  immunity to  the  1 s t,  3 rd , 4 th  and 5 th ;
/
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5 th ; and a l l  4 re in o c u la tio n s  took in  mouse 726B. In  a l l ,  o u t o f  
114 re in o c u la tio n s  66 were unsuccessfu l in  p roducing  in fe c t io n  and 48 
su ccess fu l (Tab le  XXI Va).
3  m ice — /OlA, 76OS and 7?2A — which had re s is te d  4 to  6 
consecu tive  re in o c u la tio n s  w ith  acme p k ra s ite s  were re in o c u la te d  
w ith  app rox im ate ly  tw ice  the usua l number o f  organisms; 1 became 
in fe c te d ,  th e  2nd was immune and p robab ly  a lso the  3 rd . Number 7D1A 
was e x c e p tio n a lly  re s is ta n t  to  re in o c u la tio n , as a 2nd double s tre n g th  
inocu lum  and a lso re in o c u la tio n  w ith  the  whole h e a rt blood o f  a 
h e a v ily  in fe c te d  mouse a t acme, fa i le d  to produce in fe c t io n .
In cu b a tio n  P e riod  o f  R e in fected Mice 
Compared wi t h  That o f  Cont r o ls .
O f the  57 in o c u la  which were used to  re in o c u la te  sets o f  from 
2 to  5 cured m ice, 26 fa i le d  com plete ly to produce in fe c t io n ,  w h ile  
a l l  the  corresponding c o n tro l anim als — 1 and o c c a s io n a lly  2 f o r  
each se t — became in fe c te d . In  the  rem aining 31 se ts  o f  cured m ice, 
some o r  a l l  became re in fe c te d ; the  in cu b a tio n  p e r io d , except on 3 
occasions in  which they corresponded, being on the  average 4 days 
lo n g e r  than th a t  o f  the  un tre a te d  c o n tro ls . Th is  i s  in te rp re te d  
as in d ic a t in g  a s l ig h t  degree o f  re s is ta n ce  to  re in o c u la tio n  w ith  
th e  homologous s t ra in .  ' Two mice ( 7 ^ 3  and 726B — Table XV), 
re in o c u la te d  a t  d i f fe r e n t  tim es, were the  o n ly  anim als whose in c u b a tio n
p e r io d s  were p ro tra c te d  beyond those o f  the c o n tro ls  by more than 
7 days — 11 and 17 days t i l l  scanty p a ra s ite s  appeared.
Cured /
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Cured Acme I n fe c t io n s  Reinoculated w ith  Chronic Trypanosomes.
As w ith  S tra in  I ,  mice cured o f  an acme in fe c t io n  showed no 
im m un ity  to  re in o c u la tio n  w ith  random chron ic  trypanosomes — thus 
9 m ice which had proved immune to re in o c u la tio n  w ith  acme trypanosomes 
on 1 o r  more occasions a l l  became in fe c te d  p rom ptly  when re in o c u la te d  
w ith  ch ro n ic  p a ra s ite s  o f  S tra in  I I .  A s ig n if ic a n t  r e s u lt .
Cured Chronic In fe c t io n s  R einoculated w ith  Acme Trypanosomes.
O nly 6 animals cured o f  a ch ron ic  in fe c t io n  were te s te d  fo r  
im m unity  responses owing to  the  d i f f i c u l t y  o f  e f fe c t in g  cure in  such 
cases. As w ith  cured acme mice, h a l f  proved re s is ta n t  to  re in o c u la tio n  
w ith  th e  acme p a ra s ite s . A l l  however, became in fe c te d  a f te r  e ith e r  
th e  2nd o r  the  3*^ re in o c u la tio n  (d e ta ils  are given in  Table XXVI).
A l l  which became re in fe c te d  rece ived a dose o f  1 /3 ,000 g. No. 897; 
t h is  f a i le d  to  cure 4 animals — 3 a f te r  the  1 s t re in fe c t io n  and 1 
a f te r  the  2nd — consequently no fu r th e r  re in o c u la tio n s  could be 
te s te d  in  these anim als. A tendency to  im m unity a f te r  severa l 
re in o c u la t io n s  was observed in  mouse 696A, which became re in fe c te d  
a f te r  the  1 s t  and 2nd re in o c u la tio n s , bu t proved immune to  the  3rd ,
4 th , 5t h  and 6t h  re in o c u la tio n s  (Table XXV).
Summary.
I n  m ice cured o f  an acme S tra in  I I  in fe c t io n  a s o l id  im m unity to
re in o c u la t io n  w ith  acme trypanosomes was ev iden t o n ly  in  about 50 P61* 
ce n t, o f  the  anim als, whereas such immunity occurred  in  100 pe r cent, o f
th e  S tra in  I  in fe c t io n s  under the  same circum stances. The responses 
were independent o f  the  in te r v a l  between dosage w ith  the  drug and the  
re in o c u la t io n ,  and independent o f  the amount o f  drug g iven. Animals 
which proved immune were repea ted ly  re in o cu la te d ; both“ these and in  /
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i n  those  which were cured a f te r  successfu l re in o c u la tio n s , the subsequent 
re in o c u la t io n s  again each produced in fe c t io n  in  about 0^ p e r cen t*, whereas 
cured m ice o r ig in a l ly  in fe c te d  w ith  acme S tra in  I  p a ra s ite s  w iths tood  
up to  20 re in o c u la tio n s  w ith  acme trypanosoraes. Those re in fe c t io n s  
which developed w ith  S tra in  I I  showed a s l ig h t  p ro tra c t io n  in  the 
in c u b a tio n  p e r io d .
Cured c h ro n ic a lly  in fe c te d  S tra in  I I  m ice, on re in o c u la tio n  w ith  
acme p a ra s ite s  g ive  the  same responses as cured acme anim als, but no 
im m unity  was observed in  cured acme in fe c te d  mice to  re in o c u la tio n  w ith  
c h ro n ic  p a ra s ite s .
D iscussion.
The ou ts ta n d in g  fe a tu re  o f  the re s u lts  i s  th a t  S tra in  I I  i s  much 
in f e r io r  to  S tra in  I  in  im m unising power as te s te d  by the  behaviour o f  
an im als cured a t acme and re in o c u la te d  w ith  the  homologous acme s t ra in .
The fa c t  th a t  about 50 pe r cent, o f  such a ire d  animals become re in fe c te d  
a f te r  a s l ig h t ly  p ro tra c te d  in cu b a tio n  p e rio d , h inders  s a t is fa c to ry  
ob se rva tio n s  along the  l in e s  fo llow e d  w ith  S tra in  I .
Even when such re in fe c te d  animals are cured and again re in o c u la te d  
o n ly  about 50 p e r cent, r e s is t  and th is  i s  the  case a f te r  severa l 
subsequent re in fe c t io n s  and cures. E ve n tu a lly , however, an inc rease  
i n  the  im m unity appears to occur.
So f a r  as the l im ite d  number o f  obse rva tions p e im it a conclus ion , 
i t  appears th a t  when an in fe c t io n  becomes ch ron ic , the trypanosomes 
undergo im m unological changes s im ila r  to  those o f  S tra in  I ,  i . e .  the re  
i s  an a d d it io n  to  the  o r ig in a l recep to rs , and n o t a replacement o f  
th e  la t t e r .
Cross /
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CROSS IMMUNITY RESPONSES.
In  o rd e r to  a s c e rta in  whether cross im m unity e x is ts  between S tra in s  
I  and I I ,  m ice o f  each s t ra in  in fe c te d  w ith  acme p a ra s ite s  and cured 
a t  acme, were re in o c u la te d  w ith  acme p a ra s ite s  o f  the  o th e r  s t ra in .
M ice Cured o f  Acme S tra in  I  In fe c t io n s  and R e inocu la ted  
w ith  Acme S tra in  I I .
12 m ice cured o f  S tra in  I  in fe c t io n  (6  o f  which had re s is te d  re ­
in o c u la t io n  w ith  acme S tra in  I  p a ra s ite s )  p rom p tly  became in fe c te d  
when in o c u la te d  w ith  trypanosoraes o f  S tra in  I I ,  and showed no p ro tra c t io n  
o f  th e  in c u b a tio n  p e rio d  beyond th a t  o f  the  c o n tro l.  A f te r  t l i i s  was 
cured in  10 anim als a 2nd s im ila r  re in o c u la t io n  w ith  S tra in  I I  p a ra s ite s  
caused in fe c t io n  in  o n ly  1 ; 6 o f  the 9 r e s is ta n t  mice rece ived  a
fu r th e r  inoculum  o f  S tra in  I I  p a ra s ite s , which was re s is te d  by 5 —
Tab le  XXVII g ives d e ta i ls .  These few experim ents in d ic a te d  th a t  mice 
cured o f  acme S tra in  I  in fe c t io n s  d id  n o t possess im m unity a ga ins t 
actae S tra in  I I  p a ra s ite s . But the  fu r th e r  re s u lts  suggested th a t  
when the  l a t t e r  in fe c t io n  was cured, im m unity to  subsequent re in o c u la tio n s  
w ith  S tra in  I I  p a ra s ite s  developed more re a d i ly  than in  anim als which 
had never been in fe c te d  w ith  S tra in  I ,  the  d iffe re n c e  be ing s ig n if ic a n t  
a ltho ugh  n o t h ig h ly  so.
E f fe c t  o f  a Cured S tra in  I  In fe c t io n  on th e  Subsequent 
Development o f  Im m unity a f te r  In o c u la t io n  w ith  S tra in  I I .
To te s t  th is  p o in t  fu r th e r ,  8 mice were in fe c te d  w ith  an inoculum  
c o n s is t in g  o f  a m ix tu re  o f  both s tra in s .  The in c u b a tio n  p e rio d s  o f  the  
c o n tro ls  in o c u la te d  w ith  the  separate s t ra in s  and o f  the  m ice re c e iv in g
th e  mixed inoculum  were a l l  o f  the same d u ra tio n . A f te r  cure , the  
te s t  anim als ¥#ere re in o c u le te d  repea ted ly  w ith  S tra in  I I  p a ra s ite s
/
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p a ra s ite s  (TahLe X X V III) , The f i r s t  re in o  cu l e t io n  w ith  S tra in  I I  
p a ra s ite s  in  these mice produced about a 50 p e r cent, im m unity  response, 
ju s t  as in  anim als no t in fe c te d  yd th  S tra in  I .  The 3 rd , 4 th  and 5th  
re in o c u la t io n s  w ith  S tra in  I I  trypenosomes were com ple te ly  re s is te d ;  
t h is  r e s u lt  i s  h ig h ly  s ig n if ic a n t  and supports  the conc lus ion  from 
th e  p re v io u s  experim ent (p reced ing  paragraph) th a t  g re a te r im m unity 
to  S tra in  I I  p a ra s ite s  i s  produced in  th e  presence o f  S tra in  I  
a n tib o d ie s . One animal w ith s to o d  up to  7 re in o c u la t io n s , bu t a 
2nd became in fe c te d  by a 6 th  re in o c u la t io n .
Mic e  Cured  o f  Acme S tra in  I I  I n fe c t io ns and R e inocu lated 
w ith  Acme S tra in  I .
8 anim als cured o f  S tra in  I I  in fe c t io n  a l l  became in fe c te d  on 
re in o  cu l a t ic n  yd th  S tra in  I  p a ra s ite s , a f te r  a normal in c u b a tio n  p e r io d .
Thus, th e re  i s  no cross im m unity between the  2 s t ra in s ,  i . e .  
anim als cured a t acme a f te r  in fe c t io n  w ith  acme trypanosomes o f  S tra in  
I  became in fe c te d  on re in o c u la tio n  w ith  acme p a ra s ite s  o f  S tra in  I I  
and v ic e  versa.
In  s p ite  o f  t h is ,  im m unisation to  S tra in  I I  appears to  be 
f a c i l i t a t e d  by the  occurrence o f  an im m unity re a c tio n  to  S tra in  I .
(
, ■ \
SECTION V II .
F IELD TRIALS QF NO; 897 iiND NO. I 555 ON T. CONCX)L£NSE INFECTIONS.
1
FIELD TRIALS OF NO. 897 and NO. I 555 on T. CONGOLENSE INFECTIONS.
CompoundJNo*_ 89 7«
T. congo le n se in fe c t io n s  in  c a t t le  have been tre a te d  w ith  t h is  
drug by Hornby, Evans and W ilde ( I 943) in  Tanganyika, Carm ichael and 
B e ll (1944^*) in  Uganda and M arsha ll in  N ig e r ia  (p re lim in a ry  communic­
a t io n  to  Department o f  S c ie n t i f ic  and In d u s t r ia l  Research, 1943, o f  
experim ents in te r ru p te d  by an in te r c u r re n t  outbreak o f  p le u ro ­
pneumonia). They re p o r t fa vo u ra b ly  on i t s  a c tio n  and s ta te  th a t  
from  t h e i r  experience i t  has a h ig h  p lace  among the try p a n o c id a l 
agents te s te d  aga ins t t h is  in t r a c ta b le  in fe c t io n ,  a lthough  du T o it
(comm unication to  the  N a tio n a l I n s t i t u t e  f o r  M edica l Research, dated I
!!
September 1941) d iscon tinu ed  t r i a l s  w ith  the drug a f te r  fa i lu r e s  in  j
t r e a t in g  3 sheep in fe c te d  w ith  T. cong o lense. Hornby e t a l .  and J
ii
Carm ichael and B e ll used 0 .5  o r  1*0 pe r cent, aqueous s o lu t io n ,  w h ile  ij
M a rsh a ll used a 0 .1  p e r cen t, s o lu tio n ^  a l l  adm in is te red  the  drug in  ji
the  p ro p o rt io n  o f  1 ,5  o r  2 mgm. p e r k i l o  o f  body w e igh t. The lo w  |! 1
ij
s o lu b i l i t y  o f  No. 897 i s  a d isadvantage, as a la rg e  volume o f  s o lu tio n
t
i s  re q u ire d  fo r  dosage. Hornby e t aL, observed severe lo c a l re a c tio n s
j
a f te r  a dose o f  2 mgm. A i l o  g iven subcutaneousiy. A lo c a l  re a c tio n  j
j
which does n o t re s u lt  in  permanent lameness fo llo w s  the  a d m in is tra tio n  
o f  such doses in tra m u s c u la r ly . j I
I n fe c t io n s te s te d  and stage o f  in fe c t io n  a t tim e o f  tre a tm e n t. Hornby jj
n
e t  a l .  used zebus n a tu ra l ly  in fe c te d  w ith  T. congolense, o th e rs  |j
e x p e rim e n ta lly  in fe c te d  which were tre a te d  from 2 days to  5 weeks a f te r  H
th e  f i r s t  appearance o f  p a ra s ite s  in  the  blood, and a lso anim als which had 
re lap sed  a f te r  trea tm en t w ith  No. 897 o r  o th e r  drugs. C a tt le  |
e xp e rira e n ta lly  in fe c te d  w ith  2 s tra in s  o f  T. congolense were t re a te d  by /  I
by Carm ichael and B e ll ,  tre a tm e n t being delayed u n t i l  the  in fe c t io n  
had become w e ll e s ta b lish e d  ( "c h ro n ic " ) • The course o f  th e  in fe c t io n  
in  u n tre a te d  hosts  was n o t described  by e ith e r  group o f  workers. 
M a rsh a ll used a s t ra in  which had been re c e n t ly  tra n s m itte d  by w ild  
G loss ina , In  sheep i t  caused a ch ron ic  und u la n t type  o f  in fe c t io n ,  
bu t i t  was much more v i r u le n t  f o r  c a t t le ,  k i l l i n g  most o f  then in  
14 to  36 days a f te r  in o c u la t io n .  In  the  f i r s t  se t o f  anim als te s te d
th e  drug was adm in is te red  3 to  8 days a f te r  the  p a ra s ite s  appeared in
th e  blood? in  the  second se t a f te r  10 to  17 days.
C r i t e r ia  o f  cure. Horn by e t a l , considered cure had been
e ffe c te d  i f  weekly exam inations o f  the  b lood were a l l  n e g a tiv e  fo r
6 months, the  general c o n d itio n  o f  the  animal was good and also
th e  b lood  haemoglobin va lue  was "reasonab ly  h ig h ". Carmichael and 
B e ll re p o rte d  cures a f te r  d a i ly  n e g a tive  b lood exam inations fo r  4 
months, th e  animals be ing w e ll and su b in o cu la tio n s  o f  the  b lood in to  
s u s c e p tib le  c a t t le  p ro v in g  n e g a tive . Constant obse rva tion  f o r  a 
p e r io d  o f  a t  le a s t  6 months, in c lu d in g  re g is t r a t io n  o f  any 
f lu c tu a t io n s  in  tem perature, was considered by M a rsh a ll to  be the  
minimum re q u ire d  to  assess the  va lue  o f  the  trea tm en t.
The re s u lts  o f  trea tm en t are shown in  Table XXIX,
Treatm ent o f  re la p se s . 44 days a f te r  the  i n i t i a l  trea tm en t
th e  27 re lapsed anim als were re tre a te d  by Carmichael and B e ll w ith  an 
in tra ve n o u s  dose a t the  ra te  o f  2 m g m ./k ilo ; 22 o f  them were cured.
The 5 rem ain ing anim als rece ived  2 fu r th e r  s im ila r  trea tm en ts , 
re la p s in g  a f te r  each. Of the  21 in fe c te d  beasts tre a te d  w i th '1 .5  
m gm ./k ilo  No. 897 in tra m u s c u la r ly  by Hornby e t  a l . ,  13 re lapsed ; 4 
o f  these were cured a f te r  a s im ila r  in je c t io n  in to  ano the r q u a rte r . The
-  67 -
The second re lap se  in  the  rem ain ing 9 anim als was tre a te d  by weekly 
in tra ve n o u s  dosage a t  the  ra te  o f  2 m gm ./k ilo ; 6 an im als were cured 
by t h is  trea tm en t — 2 re q u ir in g  o n ly  1 in tra ve n o u s  in je c t io n .
Treatment w ith  ano the r drug was commenced in  th e  3 rem ain ing an im als, 
as the  in fe c t in g  p a ra s ite s  were considered to  be fa s t  to  No. 897*
General scheme o f  t r e at ment. Hornby e t a l .  recommend one 
in tra m u s c u la r  in je c t io n  o f  1 ,5  m gm s/k ilo ; t h is  to  be repeated in to  
ano the r q u a rte r i f  a re lapse  occurs; and 3 in tra ve n o u s  doses o f  2 
mgm, / k i l o  a t  weekly in te r v a ls  i f  a fu r th e r  re lap se  i s  observed.
Carm ichael and B e ll p re fe r  to  in tro d u c e  the drug in tra v e n o u s ly  o r  to  
a d m in is te r i t  s im u ltaneous ly  by the  in traven ous  and in tra m u s c u la r ro u te s . 
M a rsh a ll advised the  in tra m u s c u la r method o f  a d m in is tra tio n  ra th e r  
than th e  subcutaneous.
Hornby e t a l .  and Carmichael and B e ll considered th a t  trypanosomes 
fa s t  to  No. 897 were ob ta ined  when repeated trea tm en t o f  re lapses  
f a i le d  to  produce cure. The fo rm er workers, however, were ab le  to  
cure such in fe c t io n s  by trea tm ent w ith  antimosan. Hornby e t a l .  and 
M a rsh a ll found th a t  so fa r  as th e i r  s t ra in s  o f  T. congolense were 
concerned, fa i lu r e s  were more common in  anim als tre a te d  a t an e a r ly  
stage o f  the  in fe c t io n  than in  those in  which trea tm en t was postponed 
u n t i l  the  in fe c t io n  was w e ll e s ta b lis h e d ; a c c o rd in g ly , as Hornby e t  a l.  
s ta te ,  the consequent development o f  a n tib o d ie s  appeared to  "more than 
compensate fo r  the disadvantages o f  increased  anaemia and weakness."
I t  should be noted th a t  the  p resen t au thor wo ik in g  w ith  mice found 
th a t  bo th  s tra in s  o f  T. congolense respond b e t te r  to  trea tm en t a t  th e
acme stage than a t e ith e r  the  pre-acme o r  the  ch ro n ic  stages (Tab les 
IV  and V I I ) .
In  /
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In  a d d it io n  to  th e ra p e u tic  t r i a l s ,  Carm ichael and B e ll c a r r ie d  o u t 
te s ts  on th e  p ro p h y la c ti c  ^ ac tion  o f  No. 897* They found th a t  the  drug 
in  the  la rg e r  dose above-mentioned p ro te c te d  c a t t le  a g a in s t a heavy 
in o c u la t io n  o f  T. congole n se  u p  to  48 hours a f te r  a d m in is tra tio n . Th is  
they  considered m igh t be o f  va lue  f o r  p ro te c t in g  anim als d u rin g  sh o rt 
jo u rn e ys  through f l y  b e lts ,
P henanthrld in ium  compound No. 1555*
T r ia ls  c a r r ie d  o u t by Carmichael and B e ll (1944^) in d ic a te  th a t  
t h is  drug i s  more s u ita b le  than No. 897 fo r  use in  the  f ie ld .  I t  can be 
adm in is te red  subcutaneously w ith o u t se rious  lo c a l  reactions?  s in g le  
doses o f  2 m gm ./k ilo  o f  a 1 o r  2 p e r cen t, s o lu tio n  in  most cases 
e ffe c te d  s t e r i l i s a t io n .
Treatm ent o f  T.congolense In fe c t io n s  o f  C a tt le  by No.1553*
Mode o f  
Admini s t ra t io n .
Dose 
in  m g m ./k ilo .
No.cured /  No. tre a te d
In tra m u s c u la r 2.0 (2$0 4 /4
In tra ve n o u s 2.0 (250 4 /4
Subcutaneous 2.0 (250 8A 2
2.0 (1%) 3 /3
1 -5  ( 3 0 4/4
1 .5  (1^) 4 /4
1.0  (2$) 4 /4
1 .0  (150 4 /4
The f ig u r e  in  b racke ts  a f te r  the  dose g ives  percentage s o lu t io n  used.
Treatment o f  re la p s e s. The 4 re lapsed  anim als were re tre a te d  w ith  
th e  same dosage subcutaneously? a l l  were cured. S ince the  compound i s  
r e a d i ly  s o lu b le  in  w ater, the  volume o f  s o lu tio n  re q u ire d  i s  r e la t iv e ly  
sm a ll. In  mice No. 1553 proved s l ig h t ly  more to x ic  than No. 897 bu t 
th e ra p e u t ic a lly  i t  was somewhat more a c t iv e  than No. 897? s ince  sm a lle r
sm a lle r doses e ffe c te d  cure, i . e .  the  " th e ra p e u tic  in d e x " i s  h ig h e r.
I t  had th e  added advantage o f  causing no in d u ra t io n  in  maximal doses.
D iscussion o f  the  R esu lts  o f  F ie ld  T r ia ls  i n 
th e  L ig h t  o f  Experim enta l Work.
(1) I t  i s  g r a t i f y in g  th a t  favou rab le  re p o r ts  on the  a c tio n  o f
drug No. 897 on T. congolense in fe c t io n s  in  c a t t le  were re ce ive d  from 
th e  d i f f e r e n t  re g io ns , s ince  some fa i lu r e s  m igh t have been expected.
I t  has been shown th a t  the  2 experim enta l s t ra in s  o f  the, trypanosome 
d i f f e r  m arkedly in  (a) v iru le n c e , (b) c u r a b i l i t y  w ith  a s in g le  
trea tm en t, (c )  response to  repeated trea tm en t o f  re lapses  and (d) in  
th e  im m unity response which seems to  p la y  an im p o rta n t p a r t  in  conducing
to  cure. A cco rd ing ly , ve ry  cons iderab le  v a r ia t io n  in  the  t r a c t i b i l i t y
o f  in fe c t io n s  in  the  f ie ld  m igh t be a n t ic ip a te d .
(2) The stage o f  the  in fe c t io n  a t the  tim e  o f  tre a tm e n t o f  
experim enta l in fe c t io n s  should be noted, as i t  has been shown th a t  
in  m ice the  c u r a b i l i t y  o f  an in fe c t io n  due to  e ith e r  s t ra in  a l te r s  
co ns ide rab ly  as the  in fe c t io n  progresses. W ith  S tra in  I I  decrease 
in  c u r a b i l i t y  i s  m an ifested  both  be fo re  the  acme stage and a lso
3 to  4 days a f te r .
( 3) The d i f f i c u l t y  o f  p roducing  a drug r e s is ta n t  s t ra in  under 
experim enta l c o n d itio n s  and also the  fa c t  th a t  w ith  one s t ra in  
repeated trea tm en t o f  re lapses e f fe c ts  cure, in d ic a te  th a t  No. 897 
i s  a va lu a b le  drug f o r  use in  the  f ie ld .  The re s is ta n c e  to  th e  drug 
shown by re lapsed  in fe c t io n s  which has been no ted  by Hornby e t a l .  and 
Carm ichael and B e ll ,  can most p robab ly  be a t t r ib u te d  to  the  c h ro n ic ity
o f  the  in fe c t io n  ra th e r  than to  tru e  acqu ired  drug re s is ta n c e . Thus 
i t  has been found in  the p re se n t work th a t  in  mice the  c u ra t iv e  dose /
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dose f o r  a ch ron ic  in fe c t io n  may be a t  le a s t  5 "to 10 tim es th a t  
re q u ire d  a t  acme (Tables IV  and V I I ) .
(4) Imm unity to  the  homologous trypanosomes fo llo w in g  the  cure 
o f  acme in fe c t io n s  in  one s t ra in  i s  a b s o lu te ly  s o l id ,  whereas o n ly  
a 50 p e r cen t, im m unity i s  observed under the  same c o n d it io n s  w ith  
th e  o th e r  s t ra in .  I f  such a s o l id  im m unity can be demonstrated in  
th e  f i e l d  i t  may be p o s s ib le  to  u t i l i s e  i t  to  p ro te c t  an im als passing  
th ro ugh  in fe c te d  b e lts  by p re v io u s ly  in fe c t in g  them and then producing 
cure w ith  the  drug. Also from experim enta l work i t  would appear th a t  
under f i e l d  c o n d itio n s , a f te r  cure o f  c e r ta in  s tra in s  o f  T. congolense. 
red.nfect.ions would n o t o c c u r,w h ile  under s im ila r  c o n d it io n s  w ith  o th e r  
s t ra in s  re in fe c t io n s  m igh t be expected.
( 5) I t  has been shown e xp e rim e n ta lly  th a t  in  m ice a g re a te r 
degree o f  im m unity was m anifested to  la b o ra to ry  S tra in  I I  p a ra s ite s  
in  the  presence o f  a n tib o d ie s  to  S tra in  I  than in  anim als which had 
never been in fe c te d  w ith  the  la t t e r .  A cco rd in g ly , i t  m igh t be 
expected th a t  a more s o l id  im m unity would fo llo w  cure o f  a mixed 
in fe c t io n  w ith  severa l s t ra in s  o f  T. congolense than would occur 
a f te r  in fe c t io n  w ith  a s in g le  s t ra in .  T h is  would app ly  p a r t ic u la r ly  
in  the  case o f  a s t ra in  w ith  r e la t iv e ly  poor im m unising p ro p e r t ie s .
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APPENDIX
TABLE I
S tra in  I .
Percentage o f  anim als whose in fe c t io n  had th e  in c u b a tio n  p e r io d  shown.
j In c u b a tio n  
1 (days)
Passages
101 to  150 100 Recent about 700th
14.8
18.0
~ & 3
1.6
1.-610
No. o f  
an im als aoo
TABLE I I
S tra in  I I .
Percentage o f  animals whose in fe c t io n  had th e  in c u b a tio n  p e r io d  shown.
In c u b a tio n Passages
(days) 1-10 11-20 21-33 31-40 41-60 61-80 81-100 101-200 5 9 1 - ^ o i
2 1 .2 2-5 5*2 •5
3 4 3*0 22.2 20.8 25 40.5 60 52.2 17
4 22 27-3 36. I 54.2 57*5 48.8 32.5 3<£cf 45.5
5 42.4 36. I 25, 15 9*5 5
5*4 24.5
6 30 18.2 2.8 -
2. S .4 9
7 6 9.1 2.8 j  ^4 2*5
'  81 8
\ ” ' '  ' 1
f 1 i
j No. o f  
anim als 33 36 24 80 84 80 272
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TABLE V I I I
R esu lts  o f  Treatm ent o f  T. congolense I I  w ith  sp ec ia l re fe ren ce  to re lapses .
TStage o f  ?
In fe c t io n  • R esu lt
a t  I n i t i a l ]  o f  
T re a tm e n t^  Treatment.
C
T
a t + v l
a t  acme
CR
D
K
Kp
T o ta l 
o f  which re lapsed
C
CR
N o .o f ! 
M ice, j
0
9 !
8 !
1 l 
1
D
K
Kp
K r
K t
NA
T o ta l
19
19
23
14
12
2
3
1
3
2
To”
o f  which re lapsed! 37-
No. o f  Relapses.
1 ,3 (2 ) ,  5 (3 ), 6,14 ,20 . 
4, 6,9(3) , 14, 16, 19. 
15.
14.
1
1 ( 3 ) , 2( 2 ), 3 ,4( 2 j1, 6, 82, 12, 15, so3, 21. 
2(3) , 5 , 8 ,9 ,1 1 (2 ),1 4 (2 ),19, 25.
5, 10.
12. 13. 14.
6.
11. 13. 14.
14,30-
C s ig n i f ie s  mouse cured by i n i t i a l  trea tm en t. 
CR 
D
Kp
K r
K t
NA
11 a f te r  a number o f  re lapses , 
d ied  in te r c u r re n t ly .  
c b lo ro fo m e d  in  a p ro tra c te d  re la p se .
n because o f  poor genera l c o n d it io n .
n in  an abnorm ally  la t e  re la o se .
n n because o f  c o n d itio n  o f  t a i l ,
th e re  was no response to  tre a tm e n t.
F ig u re s  in  b racke ts  in d ic a te  numbers o f  mice above 1 .
1 . 2. 35 i n each o f  these cure i s  o n ly  presum ptive in  the  case o f  1 an im al, 
dea th  having occurred  in te r c u r r e n t ly  69, 55 and 52 days a f te r  th e  la s t  
tre a tm e n t re s p e c t iv e ly .
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TABLE X I I .
f i r s t  A ttem pt to  Develop Drug R e s is ta n ce  in  S t ra in  I .
No. o f  I' I n i t i a l  ) Subsequent trea tm en ts  given when abundant 
Passage.j Treatment ! trvoanosomes were p re se n t in  the  b lood.
j a t  acme, j F igures in  b racke ts  rep resen t the  No. o f  days 
a f te r  the  p rev io us  tre a tm e n t.
(14) 1/ 75,000 g. (10) 1/ 75,000 g.
( 6) 1 /75,000 g. ( 5) i/75»ooo g.
1/ 75,000 g . i ( 2) i / 75,ooo g.
1
1/50,000 g . i '(4) 1 /50 ,000 g.
>
1/ 30,000 g .;
t "
1-
( 2) 1/ 15,000 g.
1/ 15,000 g.
10 1/12,000 g. (3) 1/ 12,000 §.
TABLE XEII
Second Attempt to Develop Drug Resistance in  S tra in  I .
— — i. .. .fin. — . —
' No. o f  
Passage.
.................. . .. . . -
1
Dose o f  No. 897 in je c te d
when scanty trypanosoraes
were p resen t in  the  blood, 
- • —  -  -
1/ 200,000 g.
No.
9 & 10
Dose. 
i A i 5,ooo g.
2 no drug. 11 iA o o ,o o o  g.
3 & 4 1/ 200,000 g. 12 & 13 1/75 ,000  g. 
---------------------
5 & 6 . lA 7 5 ,0 0 0  g. 14 1/ 60,000 g.
7 i A  50*000 . g. 15 & 16
-
1/ 50,000 g.
1■
-8 lA 33>000 g.
TABLE XIV._
Attempt to  Develop Drug Resistance in  S tra in  I I .
I Dose o f  No. 897 in je c te d  '
^ ° *  0 v:hen scan t v  trypanosomes | No. 
Passage. were p resen t in  the  b lood, j
> ........... . 1
f
Dose.
1. 1 ! 1/ 750,000 g. 12 1/ 200,000 g.
!
2 1/ 500,000 g. 13 to  15 lA *50 ,000  g.
| |
3 1/ 750,000 g. | 16 to  18
I 1
lA 3 3 ,0 0 0  g.
4 1/ 650,000 g. 19 & 20 ' ■ 1 l A 20,000 g. 1
!u _____,___ _ _i
5 1/450,000 g.
____ _____ ____
21
t
1/ 110,000 g. 1
6 1/ 300,000 g. 22 to  24 iA o o ,o o o  g.
7 1/450,000 g. 25 & 26
1
1/ 90,000 g. 1
1j
—
...
..1
 
—
1
1
VO 
1 
CD
 
J < 1 1
1 
1
1/ 300,000 g. 27 1/B0 ,000 g.
L __________
1/ 250,000 g.
j 1
28 & 29 j 1/ 75,000 g. j
1 1i .
i .
j 10 1/ 200,000 g. 30 to  32
1
1/ 70,000 g. 1
i1 
1(
HH
J______ j 1/ 300,000 g.* .........  ..... . 33 & 34 1/ 60,000 g. i_________________i
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TABLE XVI
STRAIN ^
Summary of~ R e inocu lations»
O r ig in a l In fe c t io n , 1 s t  R e in o cu ls tio r i* 2nd R e inocu la .tion*
\
Nf n
TABLE X V I ( c o n t d . ) .
STRAIN I_ 
Summ aiyof R ^ n o c u lf  t io n £ .
2nd R e in o cu la tio n1 s t  R e in c c u la t io n .O r ig in a l In fe c t io n
th is 1
CK3
A -  acme Ch = ch ro n ic . I  = immune. NI = n o t immune.
The f ig u r e  a f t e r  I  o r  NI re p re s e n ts  the, number o f  m ice re a c t in g  in  th e  way
shovn.
IM
MU
NI
TY
 
EX
PE
RI
ME
NT
S 
WI
TH
 
ST
RA
IN
 
I
Ww M M
O
CO
rH
O o
M M
O
ITS OS
Oo o
MH.
O•»Ki
CM
O
MW MM
m
co
oo o
On
CO
-P
M
0  g  
Cl *H
1 §
•H Cl 
II II
M h i
a
0)
o•Hd
2Ao
II II
3•H
-P•H
S•r-i
u0
-P
"a
co
s*
rc5
O
0)3^
<d,d
-P
CO-p
8
CO
0u
S'JH
do•H
•p
cd
H
£
§
*8Ch
o
a)
&
0A
-P
0
-PCM
cd
CO
t
a
cdJHA
r-
OS
CO
oa
ttO
ooo•vKi
o
0
CO
-d
•p
■g
0Cc*"<o
to
0
d
do
cd
od
fn
fH0
-P
cd
t30P,O
Tl
&
d o•rt £
0 . 0  
U -P  0
s s ' SvH S *H 
hh -P
0 0 8X! U ,d 
E-i -P  *3
§1
|
2 |
&
E-U
i
M ,
S i
1CQ k
° tHI
S I
o ;
w t
to
2 '
5 1
* !-P I
► I
s i
I ? 1<5 t
O l  
S  I
M (w
o ]
Hi
3S i
P
O
CO
CO
16
rH
s
-p
p
O
O
P
O
fl)
o
H
Q
t8
'O , 
o  .
t i :
a> ,
P-t i
P  \
•h  1 a> p  , o
JSlS
S [ t3 
P  . ®  
M  t P
I «J
i l
« O 
. P
mI CQ
5
CQ
in
rH
r -
i—i
CQin
KM
in
o
rH
<in
i n
rH
VO
CM
CQ
f tLT\
rH
OO
<*5
Pi
i n
H
f t
s ,
rH
•
s
• •
, q *=4 CQ
p Q>
o CM
o i n in
P rH rH
M
IQ P  O O •
• ®
<D O COCO a
rH
Ki
H
<5fi
CMinin
K iin
rH
OO
&in
rH
CQ
CM
K )in
H
co
c
m
P i
H
CM
1 r - T
CM
rH
CQ
-4*
<3
o
rH
K )
g \in
rH
O
H
CQ
CM
f t
rH
O
H
CQ
MO
n -in
H
CM
H
<*s
©in
rH
CQ
OM
s
rH
«*
ON
H
K 'i
; rH
! 8, p  
i p
I c  I O
! §
+ ~
i d
H?
c
P
P
P
O
o
o
P
CQin
£
00
S '
rH
UN
rH
W ---------
11 
i ,
f!" ' “
u
i1
| 1: "  
1 .
* ,
J i
L *1 t
\ [  n
•
rH
f i
p
i!
li^M
|[C t
MD
rH I i S
1 H  
1 H
i! CQ 1 CMI cn
I I  in
I . rH
pcc
c
p
* 1 *=s
i, CM
li-iF
{, rHi
mLO
rH
!i o1. o
l i «  
11H
1 CQ
! §  
1 MC
i p
i i "
. — h * -  ’■•
) i
J L - .
i i
i— ~ -
in
O
rH
CQin
K'iin
rH
O  i—I
CQ
in
H
CQ
CPl\Jin
o
H
n
CMin
CQin]
E*
rH
O
<tj f
oof
s i
rH i
! mo
o
rH
CQ
CM
CMin
rH
> PQ 
OM
. OM1 in
rH
, CQ
,  OO
t 9>  i n
CO
<2
• (
CQ 1
#
<
0
i o
* i
CQ 1
•
CQ
^  i 1 5*! . CM CM | On
^  |
CM i
i n  t 1 Cxl I m
CM
i n l « 'S  I
H rH \ 1 H rH i r rH Ii rH
-n ------
I,* J,n- iioo
I!
a-,
<tS
10
in
<
r -
moin
rH
CQ
MO
K Vin
rH
ON
ed
MO
rH
ON
<*<in
n -in
K i
cm
I <
l n -
i in
i n -
PQ
inin
rH
i n -
I<a n -  i ! ^I , in.
l rH
-
CN
I ON!»19I IT \ 
* rH
iS
i i
r -
<*• , )
OO I iS'1! I
• <
il
CQ ! iCM .ft;!
rH i i
n ' ,;
CQ i i 
m  . i
P i i l
H  I i 
i I j I
MO
CM 1!
■< . 
n -  . mo , in  .
rH i
I i
I!
S :: 
& :  i
^ il
- ' - ~T .
rO
o
t
o
Pr
Po
•H
P
aj
P
C
•H
a)
s
p
p
o
ro
c
•H
Po
•H
P
P
H
rH
-e
CD 'O 
^  QJ
P  p
P  U
§ ^ §  
CCJ r j
<y g  
p
Ph a> 
o  p  P cu
to -P
P  INO Q)
P
no
CU
p
o
0)
p
p
•H
P
c
p
tore
«5 C
TO 
P (D 
•H p  
O
S 3
B
P  s  
p
a’
cu  o
g s
XSJ
Hi
S'
I ;
P  i
® i
P t •H *0
P
P  ,
C  I
® !
p
s*£=- i 
ip ;o i 
•Hi P  I
51
S|
Sf
•H t 0) t f
<
CVJ K> lTn 
j H
—
<SITS
0)
to
i P
. O .‘S
I'MO
•oa
6
StO
osoo
p
•
0
0  52; 1
»
-p tu)
0 0
0 0P 0
p . *
H .h O
H  HCO
p
u P i
•rH P
p 0
0 P
3
t t* r
1
!
/—v 1
1
1
° s  1 1
■ 1 ___'■1• i e-»
1
1 .
M  1 l M
* 1 M | •
■ss 1 
1 i
1 535 
1
1 1
1
1 C '-
H  j LT\ I CO1
P  1 X!
O  1
1t
O 1 <1 
1 |1
______ 1
1
-------
I
1-  1----------
1
1
e~ 1
1
1
✓—>» 1 1
r -  1
K \ 1
w  ! 11
•  | I1
M  t M 1 M
•  1 1
a  1
1
1
1
1 CM*
K \ 1 1 OS
SO 1 rH 1 rH
"—" I *w ' 1
<  1 
1
<Jj 1 <4 
1
1------------- !— , J ______
• |
P  1
H  1 1
3  ! 1
0  1 1
P  1 1
«8 1 1 -
11 e■
P  I
1
1
O 1 1
•H 1 1
P  1 1
0  1 1
?  '  ’
c e
0  1 
O 1
1
1
£  ! 1•H 1 1
® 1 , 1
PS 1a 1|1
-p  1 P 1 P
0  1 
H  1 
1
a
1 P1 KS 
1_______
CM
Xi
P
o
P
II II
M
O  
•H 
• PI I
cd o
II II
«aj P ^  O
Hto
£
•H
P
0)
5
p
0
0
a
"v
PH
0)P
P
P0
P<H
cd
to
-p0
«
cd
P
P
P
•H.
0 •
P P
as
51-$
cd 0 0 
P  P  
E -«P
0
P
-P
P
P
<3
P
O
0 P
0
0 rH
P g
<H O
O P
• •H
0 h
0 0 0
P P P
P Q P
0
0 p
§
P 0 0
0 X I i*
p p P
0 0
CO 0 xa
p p
p p 0
8
0
0
.
0 p
pH 0 P  0
p „ O
0
&
•H rH  
O P
6
p
p
p
P 0
0 X!
0 P  P
p •H gs
0 P P P
•H 0 P -H
P
O 0 0
0 c P  0
<H 0 P g
,9P p•H ' •H 0 00 p  0
0 P P PX I 0 0
p <M 0 p,
p
O
S b
0 0 PhP
rP
P f t
0
P <H
P O0 «
in
fe
ct
io
n 
de
ve
lo
pe
d 
af
te
r 
re
in
oc
ul
at
io
n 
th
is
 
wa
s 
cu
re
d 
wi
th
 
a 
de
se
 
of 
l/3
»0
00
 
g. 
No
. 
89
7.
TABLEJJ.
T. Congolense
Response to  R e ino cu la tio n  in  Cured M3.ce each of  which had been 
In fe c ted. 0 r i  g in  a l l y  wi t h  Ch ro n ic  Trypano somes and were^ Reino c- 
u la te d  from th e  Same Mouse,
No, o f  
Mouse,
O r ig in a l In fe c t io n  and 
a R e ino cu la tio n  each 
d e rive d  from a Chronic 
In fe c t io n  o f  Mouse No.
1480A.> 
1480B. I 
1481A. 
1481B.
148 5A. j
!
J
1532A A  
1532B. 
1534A. \ (  
1534B. ]/
In te r v a l in  days 
between cure o f  
O r ig in a l In fe c t io n  
and R e in o cu la tio n .
R esu lt o f  
R e in o cu la tio n
11XJ. N . I . (9)
1472B. 11 N . I . (8 )
34 . N . I . (11)
34 N . I . (8 )
1473A. 12 N . I . (11)
17 N . I . (9 )
1514A. 19 N . I . (9 )
19 N . I . (11)
20 N . I . (8)
__ ^ ____ _________________ „ ___________ - - n- —
N . I .  = n o t immune.
The f ig u r e  in  b racke ts  a f te r  N . I .  rep resen ts  the  number o f  days 
between th e  in o c u la tio n  and the  appearance o f  an abundant number 
o f  trypanosomes in  the  b lood.
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Temporary F ix a tio n  o f  the  Im m unologicol Characters o f  
Passaged Chron ic  S tra in s *
* .S tra in  
. No,
No. o f  
Passage.
R esu lt o f  R e ino cu la tio n  o f  j R esu lts  in  M ice In fe c te d  
Cured Acme Mice w ith  th e  \ w ith  the  Same Inoculum  as 
Passaged C hronic S tra in .  J the  1 s t  Passage o f  the
j Corresponding S tra in  and, 
i a f te r  Cure, R e inocu la ted  
! from the  Passage Shown.
4 N . I .
•
In cu b a tio n  p e r io d  very- 
p ro tra c te d , v iz .  4 0 - 4 9  
days, 1
"
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E. *
■
H.X. I .
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-
N . I . I
F. 5 . N . I .V
T p. -  i ...» * ......■ — -..J
Im
„  -  ' ........... ...................  ■ .
I  = immune. N . I .  = n o t immune.
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TABLE XXIV
T. Congolense I I .  _ Acme S tra in .
R e s u lts o f  Reino c u la tio n s  o f  Mce^ Ciired at. Acme — the  Reinoculum 
be ing  the  Homologous St r a in  a t  Acme.
No. o f  M ice cured o f  Result, o f  1 s t  No. o f  Mice R esu lt o f  2nd
O r ig in a l In fe c t io n  and R e in o cu la tio n . R e inocu la ted  R e in o c u la tio n .
R e inocu la ted  once. tm c e .  ,
aa ■/
• i m
TABLE XXIV a
Summaiy  o f  Resul t s  of  A l l  R e in o cu la tio n s , le a v in g  o u t 
o f  accoun t ,  Pre v io u s  Responses.
1 s t  
Reinoc.
2nd 
Reinoc.
3rd  
Reino c.
4 th  
Reino c.
5th  
Reinoc.
6th
Reino c.
T o ta ls
T o ta l 40 32 21 10 . 7, 4 114
Immune 22 18 11 6 6 3 66
N ot
Immune 18 14 10
4 1 1 48
The numbers o f  mice re c e iv in g  the  successive re in o c u la tio n s  d im in ished  
in  th e  course o f  the  experiment* as some d ied  in te r c u r r e n t ly  and in  o th e rs  
i t  was im poss ib le  to  cure th e  re in fe c t io n  even w ith  h igh  dosage o f  No.
897 employed.
For code o f  re s u lts  see Table XVI,
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TABLE X X V III
Responses in  Mice cured o f a Mixed In fec tio n  to Reino d ila tio n  with
Strain I I  Parasites*
No. o f M ice
cured o f 1s t Reino eolation 2nd Reinoeolation 3rd Reinoculation
o rig in a l and Result. and Result. and Result,
mixed in fec tio n .
I  = immune.
NI = not immune.
x = 2 o f these had been reino c o lated once with
acme Strain I  parasites and proved immune.
4 th  R e in o c u la tio n  5t h  R e in o c u la tio n  6 th  Reino d i la t io n  7t h  Reino d i la t io n
and R e s u lt.
ML
and R e s u lt. and R e s u lt. and R e s u lt.
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